Medical Compliance - The Standards Navigator

Risk Management in Medical Devices: How to Build an ISO 14971-Compliant Process in 2026

Medical device risk management is the thread that connects every element of your ISO 13485 QMS — and the first place an auditor looks. This guide covers all five stages of the ISO 14971:2019 process, required documentation at each step, how to set defensible acceptability criteria, and the most common findings in notified body and FDA audits.

A step-by-step implementation guide for medical device manufacturers building or strengthening a risk management framework under ISO 14971:2019 and ISO 13485:2016

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

Your Risk Management File Is the First Thing an Auditor Opens

Not your QMS manual. Not your SOPs. Your risk management file.

That is where a notified body auditor or FDA inspector starts — because risk management in medical devices is the thread that connects every other element of your quality system. If your risk file is thin, incomplete, or disconnected from your design and production controls, the rest of your documentation will not save you.

Most medical device companies understand that ISO 14971:2019 requires a risk management process. Fewer understand what that process actually looks like when it is fully implemented — the outputs required, the decisions that must be documented, and the points where ISO 13485:2016 Clause 7.1 and ISO 14971 intersect in ways that catch teams off guard during audits.

This article walks through the complete risk management process for medical devices: what ISO 14971 requires at each stage, how those requirements connect to your QMS, and where most teams fall short.

I have spent 25 years in heavy industrial manufacturing running quality systems under ISO 9001, managing nonconformances, and building risk-based approaches to process control. When I transitioned into the ISO 13485 space, the discipline was familiar — but the regulatory stakes were different. In manufacturing, a process failure costs you time and scrap. In medical devices, the same gap in your risk file can cost you a 483 observation, a warning letter, or a market withdrawal. The rigor required is not optional, and it is not theoretical. Every output described in this article is something auditors actively look for.

Before you read further: If you have not yet assessed where your current risk management process stands against ISO 14971:2019 requirements, start there. A structured gap assessment takes less time than an audit finding.

📥 Download the ISO 13485 Gap Assessment Checklist — Free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements, including risk management obligations under Clause 7.1.

In This Guide

What ISO 14971:2019 actually requires — the full process, not just the outputs
How ISO 13485 Clause 7.1 connects to your risk management file
The five stages of the ISO 14971 process with required documentation at each step
How to set acceptable risk criteria — the decision most teams get wrong
Post-production surveillance and why it feeds back into your risk file
The most common audit findings in risk management reviews
Training options for teams building or rebuilding a compliant process

👉 Start Here: Top Resources for Medical Device Risk Management

If you are building or rebuilding your risk management process, these are the resources that will move you fastest:

ISO 14971:2019 — ANSI Webstore — The current edition of the standard. Required reading for anyone responsible for a device risk management file. Use code CC2026 for 5% off at checkout.
ISO 13485 Training — BSI Group — BSI offers ISO 13485 implementation and auditor training that covers risk management integration in depth.
ISO 13485 Training — ISOQAR — ISOQAR provides training and certification services for ISO 13485, with risk-based thinking woven throughout their courses.

What ISO 14971:2019 Requires

ISO 14971 risk management lifecycle infographic showing the seven stages of risk management in medical devices and required outputs from planning through post-production surveillance. — A visual overview of the ISO 14971 risk management lifecycle and the documentation outputs auditors expect to see.

ISO 14971:2019 is the international standard for the application of risk management to medical devices. It applies throughout the full device lifecycle — from concept through post-market surveillance.

The standard does not prescribe a specific risk analysis method. It does not tell you to use FMEA, FTA, or a risk matrix of a particular format. What it requires is a documented, systematic process that produces specific outputs at each stage.

The core framework in ISO 14971:2019 includes:

Stage	What ISO 14971 Requires
Risk management plan	Define scope, responsibilities, criteria for risk acceptability, and review activities
Risk analysis	Identify intended use, reasonably foreseeable misuse, and associated hazards and hazardous situations
Risk evaluation	Compare estimated risk against criteria — determine if risk reduction is required
Risk control	Select and implement controls; verify effectiveness; assess residual risk and any new risks introduced
Benefit-risk analysis	Where residual risk remains, evaluate whether the overall benefit outweighs remaining risk
Risk management report	Summarize the process and confirm residual risks are acceptable
Post-production information	Collect and review field data; feed findings back into risk management

Every output — the plan, the analysis, the controls, the report — must be captured in a risk management file.

How ISO 13485 Clause 7.1 Connects

ISO 13485:2016 Clause 7.1 requires that your organization document risk management requirements throughout product realization. This is not a standalone obligation — it is a QMS-level requirement that ties your risk file to your design controls, supplier management, production processes, and CAPA system.

The key connection points:

Design and development (Clause 7.3): Risk management inputs and outputs must be included in design planning. Design reviews, verification, and validation activities must all reference and be consistent with the risk management file.

Purchasing and supplier controls (Clause 7.4): Supplier-introduced risks must be identified and addressed. If a supplier failure creates a patient hazard, that scenario belongs in your risk analysis.

Production and service provision (Clause 7.5): Special processes — sterilization, labeling, software-dependent controls — require risk-based validation. Your risk file should identify where these controls are critical and what happens if they fail.

CAPA (Clause 8.5): Post-market findings, complaints, and nonconformances are data sources for your risk management process. A complaint that reveals a hazardous situation not previously identified in your risk analysis must trigger a risk file update.

Most common finding: Auditors frequently cite a disconnect between the CAPA system and the risk management file — complaints and CAPAs are processed and closed without evaluating whether the risk file needs to be updated.

If you are evaluating your current QMS against these connection points, the gap assessment checklist above covers all of them.

The Five-Stage Risk Management Process

Stage 1: Risk Management Plan

Your risk management plan is not a form — it is a governing document for the entire risk process for a specific device. It must define:

The scope of activities (which device, which lifecycle phases)
Roles and responsibilities for risk management activities
Requirements for review of risk management activities
Criteria for risk acceptability — what level of residual risk is acceptable and on what basis

The last item is where most teams take shortcuts. Acceptability criteria cannot simply reference “ALARP” or “as low as reasonably practicable” without defining what that means for your device and patient population. Auditors will push on this.

Stage 2: Risk Analysis

Risk analysis begins with a thorough description of the device — its intended use, intended users, and reasonably foreseeable misuse. From there, you identify:

Hazards (potential sources of harm)
Hazardous situations (circumstances in which people could be exposed to a hazard)
Harm sequences (how the hazardous situation leads to harm)

ISO 14971 Annex C provides a non-exhaustive list of hazard categories: energy hazards, biological hazards, environmental hazards, hazards related to incorrect output, and others. Use it as a prompt, not as a complete list.

Common analysis methods include FMEA (Failure Mode and Effects Analysis), FTA (Fault Tree Analysis), and HAZOP. Most device teams use FMEA as the primary tool. None of these methods is required by the standard — but whatever method you use must be documented and consistently applied.

Stage 3: Risk Evaluation

Once you have estimated the probability and severity of each harm, you evaluate whether each risk requires reduction. This evaluation is made against the acceptability criteria defined in your risk management plan.

If a risk exceeds your acceptable threshold, risk reduction is required. If it falls below the threshold, you still need to document the evaluation decision — not just assume silence means acceptable.

📥 If you are not confident your current risk file covers these evaluation decisions consistently, download the ISO 13485 Gap Assessment Checklist and work through Section 7 — it maps directly to these requirements.

Stage 4: Risk Control

ISO 14971 infographic showing the risk control hierarchy and residual risk evaluation process for medical device risk management. — ISO 14971 requires organizations to prioritize design controls first, verify effectiveness, and document residual risk decisions before closing risk.

ISO 14971 requires you to follow a three-level hierarchy when selecting controls:

Inherent safety by design — eliminate or reduce the hazard through design choices
Protective measures — add guards, alarms, or protective barriers in the device or manufacturing process
Information for safety — labeling, instructions for use, training requirements

You must implement controls in this order of preference. You cannot jump to warnings and labeling as your primary control if a design solution is practicable.

After implementing each control:

Verify the control was implemented as intended
Verify the control is effective at reducing risk
Assess whether the control introduces any new hazards
Re-evaluate residual risk after all controls are applied

Stage 5: Residual Risk and Benefit-Risk Analysis

After controls are in place, residual risk will remain for most devices. If residual risk exceeds your acceptability criteria even after all practicable controls have been applied, you must perform a benefit-risk analysis: does the clinical benefit of the device outweigh the remaining risk?

This analysis must be documented. “We believe the benefit outweighs the risk” is not documentation. The analysis must reference clinical evidence, intended use, and the nature and magnitude of remaining harm.

Setting Acceptable Risk Criteria

This is the decision most risk management teams get wrong, and it is the one auditors examine most carefully.

Your risk acceptability criteria must be:

Defined before you begin risk analysis — not after you have already seen your risk estimates
Based on relevant policy, standards, and guidance applicable to your device category
Specific enough to make clear decisions — a matrix with defined severity and probability ranges, not a narrative statement

What Auditors See	What They Want to See
“We aim to reduce risk ALARP”	A defined matrix with probability/severity scales and explicit acceptable/unacceptable zones
Criteria defined after the analysis was completed	Criteria established in the risk management plan before analysis began
One set of criteria applied across all device types	Criteria appropriate to the specific device and patient population
No documented basis for the criteria chosen	Reference to applicable guidance documents (IMDRF, EU MDR, FDA guidance)

Reference points that support defensible criteria include FDA guidance on risk management for device software, IMDRF guidance documents, and the introductory notes in ISO 14971:2019 itself.

Risk Control Options and Residual Risk

One of the most common gaps in risk files is incomplete residual risk documentation. Teams identify hazards, apply controls, and then fail to document the post-control risk estimate.

Every control must have:

A documented implementation record (the control was actually applied)
A verification record (the control works as intended)
A post-control risk re-estimate (residual probability × severity)
An evaluation of residual risk against acceptability criteria

If your controls introduce new hazards — which software controls, sterilization processes, and combination products frequently do — those new hazards must be analyzed through the full process. There is no shortcut.

If you are preparing for your first ISO 13485 certification audit, verify that every risk control in your file has all four of these elements documented before your Stage 1 audit. Incomplete residual risk documentation is one of the most common major nonconformances found in initial certification audits.

BSI Group offers ISO 13485 implementation training that specifically addresses risk file documentation structure, including residual risk evaluation requirements. ISOQAR provides similar training with a certification pathway.

The Risk Management File

The risk management file is not a single document. It is a collection of records that demonstrates the complete risk management process was followed for a specific device. What it must contain:

Risk management plan
Risk analysis outputs (hazard list, probability/severity estimates)
Risk evaluation records (acceptability decisions)
Risk control records (implementation, verification, new hazard assessment)
Residual risk evaluation
Benefit-risk analysis (where required)
Risk management report
Post-production information review records

The risk management report is the capstone document. It confirms that the risk management plan was followed, all residual risks are acceptable, and appropriate methods were used to obtain relevant production and post-production information.

Your risk management file must be maintained and updated throughout the product lifecycle. It is not a one-time certification exercise.

ISO 14971 risk management file infographic showing required records and how the file integrates with ISO 13485 quality management requirements. — The risk management file is the central evidence package that demonstrates ISO 14971 compliance across the medical device lifecycle.

Post-Production Information and Surveillance

ISO 14971 Clause 9 requires a systematic process to collect and review post-production information. This includes:

Customer complaints and feedback
Field service and repair reports
Medical device reports (MDRs) and vigilance reports
Published literature and adverse event databases
Post-market clinical data

This information must be evaluated to determine whether it:

Indicates previously unidentified hazards
Changes the estimated probability or severity of a known harm
Invalidates earlier risk control decisions

If it does, your risk file must be updated. Your CAPA process must have a defined trigger for escalating post-market findings to the risk management team.

Most common finding: Post-market surveillance is treated as a regulatory reporting obligation rather than a risk management input. Complaints are processed through CAPA, but the risk file is never reviewed against complaint trends. This is a major nonconformance under both ISO 13485 Clause 8.2.1 and ISO 14971 Clause 9.

Common Audit Findings in Risk Management Reviews

These are the findings that appear most frequently in ISO 13485 and EU MDR notified body audits:

✅ Incomplete risk analysis scope — Reasonably foreseeable misuse not identified or analyzed. Risk analysis covers intended use only.

⚠️ Acceptability criteria defined after the analysis — Criteria were back-filled to match the estimates, rather than established as the decision framework before analysis began.

⚠️ Missing residual risk evaluation — Controls were implemented and verified, but no post-control risk estimate was documented.

✅ Disconnected CAPA and risk file — Complaints and CAPAs processed and closed without triggering a risk file review.

⚠️ Labeling used as the primary control — Instructions for use are cited as the risk control when a design solution was practicable.

✅ Risk file not maintained post-launch — The risk file was complete at certification but has not been updated since. Design changes, new complaint data, and field findings are not reflected.

⚠️ No benefit-risk analysis where residual risk is above acceptability threshold — Teams acknowledge residual risk exceeds their criteria but do not formally document the benefit-risk justification.

Training for Your Risk Management Team

Risk management competence is a requirement, not a preference. Your team members responsible for risk management activities must be trained — and that training must be documented.

Both BSI Group and ISOQAR offer ISO 13485 training that covers risk management integration. BSI also offers a dedicated Risk Management — Requirements (ISO 14971) e-learning course for teams who need focused training on the standard itself.

If you are already certified under ISO 13485 and preparing for a surveillance audit:

If your risk team has not been formally trained on ISO 14971:2019 since the 2019 edition was published, now is the time to close that gap. The 2019 edition introduced changes to state-of-the-art requirements and manufacturer benefit-risk responsibilities that differ from the 2007 edition.

If you are building your QMS from scratch and need structured implementation support across all 8 clauses:

If you are evaluating implementation support options, review what documentation a compliant ISO 13485 QMS requires before investing in training. It will help you scope what your team actually needs to build.

FAQ

What is the difference between ISO 14971 and ISO 13485 for risk management?

ISO 13485:2016 Clause 7.1 requires that risk management be applied throughout product realization. ISO 14971:2019 is the standard that defines how to do it — the process, the required outputs, and the documentation. ISO 13485 tells you that you must manage risk. ISO 14971 tells you how. Most medical device manufacturers must comply with both.

Is ISO 14971 mandatory?

ISO 14971 is not directly mandated by law in most markets, but it is referenced as a harmonized standard under the EU MDR 2017/745 and EU IVDR 2017/746. For FDA-regulated devices in the US, compliance with ISO 14971 supports conformance with 21 CFR Part 820 design controls requirements. As a practical matter, no notified body or FDA inspection team will accept a risk management process that does not align with ISO 14971.

What is a risk management file?

A risk management file is the complete collection of records that documents the risk management process for a specific device. It includes the risk management plan, risk analysis outputs, evaluation records, control records, residual risk documentation, benefit-risk analysis (where required), the risk management report, and post-production surveillance records. The file must be maintained and updated throughout the device lifecycle.

How often should a risk management file be updated?

Your risk management file must be updated whenever there is a change to the device, its intended use, or new information that could affect risk estimates — including complaints, adverse events, published literature, or design changes. Many organizations establish a formal periodic review (annually or at defined product lifecycle milestones) as part of their post-market surveillance process.

What risk analysis methods does ISO 14971 require?

ISO 14971 does not mandate a specific method. FMEA, FTA, HAZOP, and preliminary hazard analysis are all acceptable approaches. What the standard requires is that the method be documented, systematic, and capable of identifying hazards and estimating risk. Most medical device manufacturers use FMEA as their primary method.

What is the difference between a hazard, a hazardous situation, and harm in ISO 14971?

A hazard is a potential source of harm — for example, excessive electrical energy in a device. A hazardous situation is a circumstance in which people, property, or the environment could be exposed to the hazard — for example, a patient contact point that can carry excessive current under a specific failure condition. Harm is the physical injury or damage to health that results. ISO 14971 requires that you trace the full sequence from hazard to harm for each risk identified.

How does ISO 14971 relate to CAPA in ISO 13485?

Your CAPA process should have a defined trigger for escalating complaints, adverse events, and nonconformances to the risk management team for evaluation. If a post-market finding reveals a previously unidentified hazard or changes the estimated probability of an existing risk, your risk file must be updated. Closing a CAPA without evaluating its implications for the risk file is one of the most common major findings in ISO 13485 surveillance audits.

What changed in ISO 14971:2019 compared to the 2007 edition?

ISO 14971:2019 introduced several substantive changes: clarified the concept of state-of-the-art and how manufacturers must use it; expanded and clarified the benefit-risk analysis process; updated the overall residual risk evaluation process; and revised the structure of the standard to align with ISO management system high-level structure conventions. Teams trained only on the 2007 edition may have gaps in their current process.

📥 Free Resources

These tools are available at no cost to support your ISO 13485 and risk management implementation:

ISO 13485 Gap Assessment Checklist — Free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements, including risk management obligations under Clause 7.1
ISO 9001 Roadmap — Step-by-step implementation guide for manufacturers building or improving a quality management system
Manufacturing Compliance Checklist — Practical compliance reference covering key ISO, OSHA, and quality requirements for production environments
Supplier Quality Checklist — Evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts
AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification

Not Sure What to Do Next?

🔹 Still building your understanding of ISO 13485 requirements? Start with the ISO 13485 Implementation Roadmap — it walks through all 8 clauses and how they connect before you invest in building documentation.

🔹 Ready to implement and need training for your risk management team? Both BSI Group and ISOQAR offer ISO 13485 training with risk management integration. BSI also has a dedicated ISO 14971 e-learning course.

🔹 Need to purchase ISO 14971:2019 for your quality team? Get it from the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026.

Risk management is not a documentation exercise you complete before certification and revisit every few years. It is the living framework that keeps your device safe, your quality system defensible, and your audits clean. Build it right from the start — and maintain it like the regulatory asset it is.

The Standards Navigator covers ISO 13485, ISO 14971, FDA requirements, and medical device quality management in depth. Use the resources above to move from gap to compliant.

Stay Current on Medical Device Compliance

Most teams that struggle with ISO 13485 audits are not missing knowledge — they are missing a system for keeping their risk files, documentation, and compliance processes current as requirements evolve.

Organizations that pass surveillance audits consistently have one thing in common: their quality teams are not surprised by what auditors look for. They have a process for staying ahead of requirement changes, notified body expectations, and post-market obligations.

The Standards Navigator covers ISO 13485, ISO 14971, FDA QMSR, and medical device compliance requirements in plain language for quality professionals and regulatory teams.

👉 Get updates on the medical device compliance cluster — new articles, requirement changes, and implementation guidance delivered directly to your inbox.

👉 Be first to access new free resources, including the ISO 13485 Documentation Starter Kit when it launches.

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

ISO/TR 14969 Explained: What It Was, Why It Was Withdrawn, and What Replaces It in 2026

ISO/TR 14969:2004 — the companion guidance document for ISO 13485:2003 — was officially withdrawn when ISO 13485 was revised to its 2016 edition. Quality professionals still referencing it in QMS procedures are citing an obsolete document. This article explains what ISO/TR 14969 covered, why it was withdrawn, and what replaces it: the ISO 13485:2016 Practical Guide.

The guidance document for ISO 13485 has changed — here’s what medical device quality professionals need to know today

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

The Standard That Guided ISO 13485 Compliance Is Gone — Here’s What That Means

If you searched for ISO/TR 14969, you already ran into a dead end. The document is no longer current. It was officially withdrawn.

That matters more than it sounds. Quality professionals in the medical device space still reference ISO/TR 14969 in internal procedures, training materials, and supplier documentation. Some consultants still cite it. If you are building or auditing a QMS right now, you need to know what replaced it — and whether your documentation is anchored to an obsolete source.

ISO/TR 14969:2004 was withdrawn by ISO when ISO 13485 was revised to its 2016 edition. The technical report was tied to ISO 13485:2003. When the 2016 version introduced risk-based process controls, expanded post-market surveillance requirements, and global regulatory alignment language, the 2004 guidance became misaligned — and in some clauses, actively misleading. In its place, ISO published a new handbook: ISO 13485:2016 — Medical Devices — A Practical Guide.

Now, in 2026, the stakes are higher. The FDA’s Quality Management System Regulation (QMSR) took effect February 2, 2026, formally replacing 21 CFR Part 820 with ISO 13485:2016 as the baseline for U.S. device compliance. Organizations that built their QMS on ISO 13485:2003 interpretations — or whose procedures still reference ISO/TR 14969 — face a two-layer exposure: outdated guidance and regulatory non-alignment.

I’ve seen this pattern play out in quality systems that looked solid on paper. During a QMS documentation review I supported at a contract manufacturer with FDA-regulated device components, the team found five procedures that traced their CAPA language back to 14969 interpretation. The procedures hadn’t been reviewed since 2019. They weren’t wrong, exactly — but they were missing the risk-proportionate framing the 2016 standard requires. No findings yet. That changes when the next surveillance audit runs QMSR expectations against legacy documentation.

Before you go further — if your team is preparing for ISO 13485 certification or a surveillance audit, run a gap check first:

👉 Download the ISO 13485 Gap Assessment Checklist — Free checklist for medical device manufacturers assessing their QMS against ISO 13485:2016 requirements.

In This Guide

What ISO/TR 14969 was and what it covered
Why it was withdrawn
What replaced it — the ISO 13485:2016 Practical Guide, including its structure and chapter mapping
Why 2026 is the year this gap becomes a compliance liability (FDA QMSR)
How to update your QMS documentation to reflect current guidance
Where to purchase the current standard and guidance documents
FAQ

👉 Start Here — Top Resources

ISO 13485:2016 — ANSI Webstore — Purchase the current edition of the standard. Use code CC2026 for 5% off at checkout.
ISO 13485 Training — BSI Group — Implementation, internal auditor, and lead auditor courses aligned to ISO 13485:2016.
ISO 13485 Gap Assessment Checklist — Free download. Identify where your current QMS falls short before your next audit.

What Was ISO/TR 14969?

ISO/TR 14969:2004 was a Technical Report published by ISO’s Technical Committee 210 (ISO/TC 210), the group responsible for quality management and general aspects for medical devices.

TR stands for Technical Report. Unlike a full ISO standard, a Technical Report carries no requirements. It cannot be used as the basis for certification or regulatory inspection. Its purpose was interpretive: help organizations understand what ISO 13485 required and how to meet those requirements in practice.

ISO/TR 14969 provided clause-by-clause guidance on ISO 13485:2003. It explained intent, offered implementation examples, and clarified language that auditors and manufacturers found ambiguous. The document mirrored the clause structure of ISO 13485:2003 and covered:

Scope and application — how requirements applied across different organization types (manufacturers, service providers, distributors)
Quality management system (Clause 4) — documentation requirements, records, and what was required vs. recommended
Management responsibility (Clause 5) — how top management commitment was assessed and evidenced
Resource management (Clause 6) — personnel competency requirements, infrastructure, and work environment controls
Product realization (Clause 7) — planning, design controls, purchasing, production, and process validation
Measurement, analysis, and improvement (Clause 8) — feedback, internal audits, nonconformance control, CAPA, and data analysis

Most common finding: Organizations that built their QMS procedures using ISO/TR 14969 as a reference may have clause citations, interpretive notes, or CAPA language that is now misaligned with ISO 13485:2016. Those gaps become findings during document reviews and surveillance audits.

Why Was ISO/TR 14969 Withdrawn?

Comparison chart showing differences between withdrawn ISO/TR 14969 guidance and ISO 13485:2016 Practical Guide. — Compare legacy ISO/TR 14969 guidance with the current ISO 13485 implementation approach.

ISO/TR 14969:2004 was withdrawn because ISO 13485 itself was substantially revised in 2016. When the 2016 edition introduced new and modified requirements, the 2004 guidance document became misaligned — and in some areas, a liability.

Change Area	ISO 13485:2003 / TR 14969	ISO 13485:2016
Risk-based process control	Limited risk language	Risk-based approach embedded throughout QMS structure
Regulatory requirements	Aligned primarily to EU directives	Expanded global alignment (FDA, TGA, Health Canada, EU MDR)
Post-market surveillance	General requirements	Explicit feedback loop and monitoring requirements
Software validation	Basic guidance	Expanded requirements for QMS software validation
Outsourced processes	Covered in Clause 4.1	Risk-proportionate controls based on risk and external party capability
Supplier controls	Standard purchasing controls	Risk-proportionate controls with clearer documentation requirements

A technical report tied to the 2003 standard could not guide organizations through requirements that didn’t exist until 2016. ISO withdrew the document and directed users to the replacement handbook.

What Replaced ISO/TR 14969? Structure and Clause Mapping

Timeline showing ISO/TR 14969 withdrawal and transition to ISO 13485:2016 Practical Guide and FDA QMSR requirements. — See how ISO/TR 14969 evolved into today’s ISO 13485 guidance framework.

The current guidance document is the ISO 13485:2016 — Medical Devices — A Practical Guide, published by ISO in 2017 and authored by technical experts from ISO/TC 210. In the United States it was adopted by AAMI as AAMI/ISO 13485:2016 — A Practical Guide, available through the ANSI Webstore. AAMI explicitly identifies it as the replacement for ISO/TR 14969.

The handbook runs approximately 214 pages and is organized to mirror the clause structure of ISO 13485:2016, making it a direct lookup reference when you’re working through specific requirements. Here’s how it maps:

Handbook Section	ISO 13485:2016 Clause	Key Guidance Provided
Introduction & Scope	Clause 1	Applicability across organization types; what “regulatory purposes” means in practice
Quality Management System	Clause 4	Risk-based QMS design; documentation hierarchy; outsourced process controls
Management Responsibility	Clause 5	Top management commitment evidence; quality planning; management review inputs/outputs
Resource Management	Clause 6	Competency records; infrastructure qualification; work environment controls
Product Realization	Clause 7	Design controls; purchasing controls; production process validation; sterilization; servicing
Measurement, Analysis & Improvement	Clause 8	Feedback systems; complaint handling; internal audit; CAPA; statistical methods

Beyond clause-level guidance, the Practical Guide also includes:

Regulatory notes specific to different markets — particularly useful for EU MDR and FDA QMSR alignment
Worked examples of how to apply risk-based thinking to QMS process selection and documentation intensity
Transition guidance for organizations moving from ISO 13485:2003-based systems to the 2016 edition

One practical limitation worth knowing: the Practical Guide is a 214-page document that, despite its name, is not always light reading. Industry reviewers have noted that some sections contain circular references and that the guidance on risk-based approach — one of the biggest paradigm shifts in the 2016 standard — spans only a few pages for a topic that has generated ongoing debate between manufacturers and notified bodies. Having the Practical Guide alongside a current training course is more effective than relying on the handbook alone.

👉 If you’re preparing for Stage 1 audit and haven’t run a full clause-by-clause gap check, do that before you open the Practical Guide. Download the ISO 13485 Gap Assessment Checklist to identify gaps first — then use the handbook to close them.

Why This Matters More in 2026: FDA QMSR and Dual Compliance

This isn’t just a document housekeeping issue. In 2026, it’s a compliance liability with a hard regulatory edge.

The FDA QMSR took effect February 2, 2026. It formally replaced 21 CFR Part 820 — the U.S. Quality System Regulation that governed device manufacturing for nearly 30 years — with ISO 13485:2016 as the legal baseline for U.S. medical device quality systems. Manufacturers who previously maintained a 21 CFR Part 820-based QMS now need to be running against ISO 13485:2016 requirements, including the interpretive framework the 2016 standard uses.

That has a direct impact on ISO/TR 14969 references. Here’s why:

ISO/TR 14969 pre-dates both ISO 13485:2016 and FDA QMSR. Any QMS procedure, work instruction, or training record that traces its authority back to 14969 guidance — rather than the 2016 standard and current Practical Guide — is not aligned to the regulatory expectations your FDA inspector will be applying.

Specific areas where this creates dual exposure:

CAPA requirements — 14969 guidance on CAPA pre-dates the 2016 standard’s risk-proportionate framing. FDA inspectors applying QMSR expectations will scrutinize whether your CAPA process scales corrective action depth to risk level. Procedures built on 14969 interpretation often don’t.
Post-market surveillance — The 2016 standard significantly strengthened feedback loop requirements. 14969 guidance reflects the lighter 2003 language. Under QMSR, FDA expects active post-market data feeding back into the QMS — not just complaint logs.
Software validation for QMS applications — If your document control system, CAPA software, or ERP was validated against 14969 guidance language, that validation basis needs review under the 2016 standard’s expanded software validation requirements.

I worked with a team at a supplier to a large device OEM during QMSR transition prep. Their internal audit procedure had been solid for years — well-written, consistently followed. When we mapped it against QMSR expectations, the issue wasn’t procedure quality. It was that the criteria used to determine audit frequency and depth hadn’t been updated since the 2003-era documentation. Risk-based audit scheduling — required under the 2016 standard — wasn’t in the procedure. The OEM’s supplier quality team flagged it in a pre-audit review before the FDA did. That’s the window you want to catch this in.

For a detailed breakdown of the QMSR transition and what changes for manufacturers, see FDA QSR vs ISO 13485.

How to Update Your QMS for Current Guidance

Five-step workflow for updating QMS documentation from ISO/TR 14969 to ISO 13485:2016 guidance. — Use this workflow to systematically remove obsolete guidance from your QMS.

If your QMS procedures, work instructions, or training materials reference ISO/TR 14969, here’s how to address it systematically.

Step 1 — Document search Run a controlled search of your document management system for “ISO/TR 14969,” “TR 14969,” and “14969:2004.” Flag every document where the reference appears. Include training materials and supplier quality agreements.

Step 2 — Classify each reference Not every reference creates a compliance gap. Categorize:

✅ Citation-only reference — the procedure logic is sound; only the document reference needs updating
⚠️ Interpretive reference — procedure was built around 14969 guidance that may not align with current Practical Guide interpretation (CAPA framing, risk-based audit criteria, outsourced process controls)
⚠️ Training material reference — auditors check training records; outdated citations get flagged

Step 3 — Batch the citation updates For straightforward citation updates, consolidate them into a single planned revision cycle. Update the reference from “ISO/TR 14969” to “ISO 13485:2016” or the Practical Guide as appropriate. Document the rationale in your change control record.

Step 4 — Cross-reference interpretive references against the Practical Guide For procedures built on 14969 interpretation, map them against the equivalent clause in the ISO 13485:2016 Practical Guide. Pay specific attention to: CAPA (Clause 8.5), outsourced process controls (Clause 4.1), internal audit (Clause 8.2), and post-market surveillance feedback (Clause 8.2.1). These are the areas where the 2016 guidance diverges most from 2003-era interpretation.

Step 5 — Update internal auditor training records If your ISO 13485 internal auditor training references 14969, update the training materials and re-document competency verification. This is consistently one of the overlooked items in QMS transitions — and it surfaces in audits.

Do the gap assessment before you start revising. Chasing individual references without knowing your overall QMS posture is working in the wrong order. The ISO 13485 Gap Assessment Checklist gives you the full picture first.

✅ Quick Checklist: ISO/TR 14969 Reference Review

[ ] Searched QMS document system for all 14969 references
[ ] Searched training materials and supplier quality agreements
[ ] Classified references as citation-only or interpretive
[ ] Verified CAPA procedure aligns with 2016 risk-proportionate framing — not 14969
[ ] Verified internal audit frequency and depth criteria include risk-based logic
[ ] Verified post-market surveillance feedback procedure reflects 2016 requirements
[ ] Updated training materials to remove obsolete guidance document references
[ ] Confirmed training records reflect ISO 13485:2016 Practical Guide as current source
[ ] Completed a full ISO 13485:2016 gap assessment against all 8 clauses

Where to Buy ISO 13485 and the Current Guidance Handbook

Document	Description	Source
ISO 13485:2016	The current active standard — required for certification	ANSI Webstore
ISO 13485:2016 Practical Guide	214-page official guidance handbook replacing ISO/TR 14969	ANSI Webstore — available individually or in bundles
ISO 13485 / ISO 14971 Bundle	Standard + risk management standard package	ANSI Webstore bundle
ISO/TR 14969:2004	Withdrawn — historical reference only	Available as historical document only

Use coupon code CC2026 for 5% off at the ANSI Webstore — valid through December 31, 2026. ANSI serves international buyers and offers standards in multiple languages where available.

For more on building your ISO 13485 QMS documentation, see ISO 13485 Documentation Requirements and the ISO 13485 Implementation Roadmap.

FAQ

Is ISO/TR 14969 still valid?

No. ISO/TR 14969:2004 was officially withdrawn by ISO when ISO 13485 was revised to its 2016 edition. It is no longer current and should not be used as implementation guidance for an ISO 13485:2016-aligned QMS. It remains available as a historical document only. The replacement is the ISO 13485:2016 — Medical Devices — A Practical Guide.

What replaced ISO/TR 14969?

ISO/TR 14969 was replaced by the ISO 13485:2016 — Medical Devices — A Practical Guide, a 214-page companion handbook published by ISO in 2017 and authored by ISO/TC 210 technical experts. In the United States, it was adopted by AAMI as AAMI/ISO 13485:2016 and is available through the ANSI Webstore. AAMI explicitly identifies it as the replacement for ISO/TR 14969.

Can I still reference ISO/TR 14969 in my QMS procedures?

It is not prohibited, but it creates audit risk — especially now that FDA QMSR is in effect. A reference to a withdrawn guidance document signals that your documentation system may not be current. Best practice is to replace ISO/TR 14969 citations with ISO 13485:2016 clause references or the Practical Guide, and to verify that any procedure logic built on 14969 interpretation still holds against the 2016 standard.

Does ISO/TR 14969 apply to FDA QMSR compliance?

No. ISO/TR 14969 was guidance for ISO 13485:2003. The FDA QMSR — effective February 2, 2026 — harmonizes U.S. requirements with ISO 13485:2016. QMSR compliance requires alignment with the 2016 standard and its current guidance documents. Organizations still referencing 14969 in CAPA, audit, or post-market surveillance procedures should treat QMSR implementation as the trigger to complete that cleanup.

What is the difference between a Technical Report and an ISO standard?

An ISO Technical Report carries no requirements and cannot serve as the basis for certification or regulatory inspection. ISO/TR 14969 was a TR — it existed to help organizations interpret and implement ISO 13485, not to define binding requirements. The ISO 13485:2016 Practical Guide serves the same interpretive purpose.

How is ISO/TR 14969 different from ISO 13485?

ISO 13485 is the requirements standard — it defines what a QMS must do to be certifiable. ISO/TR 14969 was guidance only — it explained how to interpret and meet those requirements. The standard is mandatory for certification; the guidance document was optional but widely used. ISO 13485:2016 is the current active standard.

Do I need to buy the ISO 13485:2016 Practical Guide separately from the standard?

Yes. The standard and the Practical Guide are separate publications. The standard defines the requirements; the Practical Guide explains clause intent and provides implementation examples. Bundle packages combining ISO 13485:2016, the Practical Guide, and ISO 14971 are available at the ANSI Webstore at savings compared to individual purchases. For manufacturers building or overhauling a QMS, having both is strongly recommended.

Where can I get ISO 13485 training that covers the current guidance?

BSI Group offers ISO 13485 training at awareness, requirements, implementation, internal auditor, and lead auditor levels — all aligned to the 2016 edition. BSI is both an accredited training provider and a recognized certification body. Pairing their implementation or internal auditor course with the Practical Guide gives you a working command of the 2016 requirements, not just familiarity with the document.

📥 Free Resources

ISO 13485 Gap Assessment Checklist — Free checklist for medical device manufacturers assessing their QMS against ISO 13485:2016 requirements before certification or a surveillance audit
ISO 9001 Roadmap — Step-by-step implementation guide for manufacturers building or improving a quality management system
Manufacturing Compliance Checklist — Practical compliance reference covering key ISO, OSHA, and quality requirements for production environments
Supplier Quality Checklist — Evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts
AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification

Not Sure What to Do Next?

🔹 Still researching ISO 13485 requirements? Start with What Is ISO 13485? for a full breakdown of the standard’s scope, structure, and who needs it.

🔹 Building or upgrading your ISO 13485 QMS? The ISO 13485 Implementation Roadmap walks you through the sequence from gap assessment to certification-ready documentation. For training on the 2016 requirements, BSI Group’s ISO 13485 courses include implementation-level coverage that goes well beyond the handbook itself.

🔹 Ready to purchase the standard? Get ISO 13485:2016 at the ANSI Webstore in digital or print. Use code CC2026 for 5% off through December 31, 2026.

The Standards Navigator covers the full medical device compliance standards landscape — from ISO 13485 implementation to FDA QMSR alignment. If your QMS has to hold up against both ISO certification and FDA inspection, the guidance document you’re working from matters as much as the standard itself.

Stay Current on ISO 13485 and Medical Device Compliance

QMS procedures built on outdated guidance don’t fail audits immediately. They fail them on the third surveillance cycle, when nobody remembers where the language came from. The FDA QMSR has made that timeline shorter.

The Standards Navigator covers ISO 13485 implementation, QMSR transition, risk management requirements, and the documentation controls that keep QMS systems audit-ready across both regulatory frameworks.

👉 Get updates on the medical device compliance standards cluster 👉 Be first to access new ISO 13485 implementation resources and checklists

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

Medical Device Compliance Standards: What Manufacturers Need to Know in 2026

Medical device manufacturers face a layered compliance framework — ISO 13485, ISO 14971, FDA QMSR, and EU MDR each impose specific requirements that must work together as an integrated system. This guide explains the core standards, how they interact, and what manufacturers need to prioritize at each stage of the compliance process.

The regulatory framework every medical device manufacturer must understand before the first audit

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

The Compliance Gap That Gets Medical Device Manufacturers in Trouble

Most medical device manufacturers don’t fail audits because they ignored the requirements. They fail because they didn’t understand how the requirements connect — and which standards they were actually obligated to meet.

The medical device compliance standards landscape is layered. ISO 13485 sets the QMS framework. ISO 14971 governs risk management. FDA regulations run parallel to international standards and don’t always align. Supplier controls, sterilization validation, design controls, and labeling each carry their own standard reference. A manufacturer who treats these as independent checkboxes instead of an integrated system is building toward an audit finding — or worse, a product recall.

The stakes are not abstract. The FDA issued 483 observations totaling thousands of findings in the medical device sector last year. Most cited documentation gaps, inadequate CAPA processes, or failure to meet design control requirements — all areas governed by the standards covered in this guide.

I’ve worked in quality systems that span heavy industrial, energy, and manufacturing environments — and the pattern I’ve seen across every sector is the same: organizations that struggle with audits are usually managing compliance requirements in silos. In the medical device world, that problem is amplified because the regulatory framework is both more complex and less forgiving than most industrial standards. Getting the structure right before your first audit is not optional — it’s the difference between certification and a warning letter.

Before you map your compliance requirements, download the ISO 13485 Gap Assessment Checklist — it walks you through every clause so you can identify exactly where your QMS falls short before an auditor does → ISO 13485 Gap Assessment Checklist

In This Guide:

The core standards every medical device manufacturer must know
How ISO 13485, ISO 14971, and FDA regulations interact
US vs. EU regulatory requirements compared
Supplier control and special process standards
Decision-stage guidance: what to prioritize based on where you are in the compliance process

👉 Start Here — Top Resources

Buy ISO 13485:2016 — ANSI Webstore — the official QMS standard for medical device manufacturers (use code CC2026 for 5% off)
ISO 13485 Training — BSI Group — training courses and certification services for ISO 13485
Buy ISO 14971:2019 — ANSI Webstore — risk management standard required alongside ISO 13485

The Core Standard: ISO 13485:2016

ISO 13485:2016 infographic showing clause structure and comparison of ISO 13485 versus ISO 9001 requirements for medical device quality management systems. — A visual breakdown of ISO 13485:2016 requirements and how they differ from ISO 9001 for medical device manufacturers.

ISO 13485:2016 is the international standard for quality management systems specific to medical device manufacturers and their supply chains. It is the foundation of medical device compliance worldwide.

ISO 13485 is not simply ISO 9001 with medical device language added. The two standards share structural similarities through the harmonized high-level clause structure, but ISO 13485 imposes stricter requirements in several critical areas ISO 9001 leaves to organizational discretion:

Requirement Area	ISO 9001:2015	ISO 13485:2016
Risk management	Risk-based thinking (general)	Formal risk management required (links to ISO 14971)
Design controls	Required	More prescriptive — validation, verification, design transfer
CAPA	Required	More detailed — specific investigation and effectiveness checks
Regulatory requirements	Not addressed	Explicitly required — must identify and meet applicable regs
Sterile product controls	Not addressed	Specific controls for sterile devices
Supplier controls	Required	More stringent — supplier qualification and monitoring
Document and record retention	Not specified	Specific retention periods tied to device lifetime

If you are ISO 9001 certified and entering the medical device market, you are not starting from scratch — but you are adding significant requirements. The gap is larger than most manufacturers expect.

If you need the standard itself, ISO 13485:2016 is available through the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026.

Most common finding: Inadequate document control — specifically, failure to control the review and approval of documents and maintain records of changes. ISO 13485 Clause 4.2 is one of the most frequently cited areas in FDA 483 observations.

Risk Management: ISO 14971:2019

ISO 14971 is the international standard for risk management applied to medical devices. It is not optional if you are manufacturing medical devices — ISO 13485 explicitly requires you to apply risk management throughout the product lifecycle, and ISO 14971 is the recognized method for doing it.

ISO 14971:2019 defines the process for:

Identifying hazards associated with a medical device
Estimating and evaluating associated risks
Controlling those risks
Monitoring the effectiveness of controls

The relationship between ISO 13485 and ISO 14971 is not optional. ISO 13485 Clause 7.1 requires organizations to establish risk management requirements for product realization. ISO 14971 is the standard that defines what “proper” risk management looks like. Auditors will look for evidence that your risk management file connects directly to your design controls, production processes, and post-market surveillance activities.

ISO 14971 vs. ISO 13485 — understanding how they interact is one of the most common questions from manufacturers building a QMS for the first time.

If your risk management files exist independently of your design control documentation — that is an audit finding waiting to happen. Most teams miss the linkage between hazard identification in the risk management file and the verification/validation activities in the design history file.

Run your gap assessment before you go further — most QMS gaps in medical device companies trace back to missing connections between ISO 14971 risk files and ISO 13485 design controls: ISO 13485 Gap Assessment Checklist

US Regulatory Requirements: FDA QMSR and 21 CFR Part 820

US medical device manufacturers operate under FDA jurisdiction. The Quality Management System Regulation (QMSR), which took effect February 2, 2026, replaced the legacy Quality System Regulation (QSR) under 21 CFR Part 820.

The QMSR represents a significant shift: it incorporates ISO 13485:2016 by reference as the baseline for device QMS requirements. This means FDA-regulated manufacturers who are ISO 13485 certified are closer to QMSR compliance than they were under the old QSR — but important differences remain.

Area	ISO 13485:2016	FDA QMSR (2026)
Scope	International	US market devices only
Complaints	Required	Required + specific MDR reporting timelines
Corrections and removals	Addressed in CAPA	Specific FDA reporting requirements (21 CFR Part 806)
UDI	Not addressed	Required for most device classes
Electronic records	Not specified	21 CFR Part 11 compliance required
Third-party audits	Required for ISO 13485 certification	FDA inspections — not third-party certification

Understanding the relationship between FDA QSR and ISO 13485 is essential for US manufacturers — the two frameworks are now more aligned than before, but they are not identical.

If you are selling devices in the US market, FDA QMSR compliance is a legal requirement, not a voluntary certification. ISO 13485 certification does not satisfy FDA obligations — it demonstrates QMS capability but does not substitute for an FDA inspection.

Comparison infographic showing US FDA QMSR and EU MDR regulatory pathways for medical device manufacturers and ISO 13485 quality system requirements. — A side-by-side comparison of US FDA QMSR and EU MDR pathways showing how medical device compliance differs across global markets.

EU Requirements: MDR and CE Marking

Selling medical devices in the European Union requires CE marking under the EU Medical Device Regulation (MDR 2017/745), which replaced the Medical Device Directive (MDD) and came into full effect in 2021. The transition deadline for legacy MDD-certified devices has been extended but enforcement has tightened significantly.

Key MDR requirements relevant to QMS:

MDR Requirement	Connection to ISO 13485
Technical documentation	Design history file / DHF requirements
Clinical evaluation	Post-market clinical follow-up (PMCF)
Unique Device Identification (UDI)	Traceability requirements
Post-market surveillance (PMS)	Customer feedback and complaint monitoring
Notified Body audit	ISO 13485 certification is typically required
Person Responsible for Regulatory Compliance (PRRC)	Management responsibility — ISO 13485 Clause 5

The MDR is more prescriptive than ISO 13485 in clinical evidence requirements. If you are exporting to the EU, your clinical evaluation report and post-market surveillance plan must meet MDR requirements that go beyond what ISO 13485 explicitly requires.

If you are selling in both the US and EU markets, you are managing two regulatory frameworks simultaneously. This is where a well-structured ISO 13485 QMS becomes particularly valuable — it provides the common foundation that both frameworks build on.

Supplier Controls and Special Process Standards

ISO 13485 Clause 7.4 imposes stricter supplier control requirements than most manufacturers new to the medical device space expect. You are not simply verifying that a supplier has a quality system — you are responsible for ensuring that purchased products and services meet specified requirements and that critical suppliers are evaluated, approved, and monitored.

For medical device manufacturers, supplier controls must address:

Supplier qualification — documented criteria for evaluation and approval
Incoming inspection — defined acceptance criteria for purchased product
Critical supplier monitoring — ongoing performance data, not just initial qualification
Supplier audits — for high-risk or critical component suppliers
Flow-down requirements — pushing your quality requirements into the supply chain

Special processes — sterilization, biocompatibility testing, coating, welding on implantable components — require additional validation documentation. The relevant standards include:

Process	Standard Reference
Sterilization (EO, radiation, steam)	ISO 11135, ISO 11137, ISO 17665
Biocompatibility	ISO 10993 series
Packaging validation	ASTM F2132, ISO 11607
Software validation	IEC 62304
Electrical safety	IEC 60601 series

These are not optional for manufacturers of the relevant device types. If your device is sterilized, you need sterilization validation documentation. If it contacts patient tissue, you need biocompatibility data. Gaps in special process validation are among the most serious findings an FDA inspector or Notified Body auditor can cite.

Design Controls and Validation Standards

ISO 13485 design controls infographic showing the Design History File process from inputs through outputs, verification, validation, and design transfer. — A visual guide to the ISO 13485 design controls process and how design inputs become validated, production-ready medical devices.

Design controls are where ISO 13485 certification and FDA compliance intersect most directly. ISO 13485 Clause 7.3 requires a structured design and development process covering:

Design and development planning
Design inputs (requirements)
Design outputs (specifications)
Design review at defined stages
Design verification (does it meet inputs?)
Design validation (does it meet user needs?)
Design transfer (can it be manufactured consistently?)
Design changes (controlled and documented)

The design history file (DHF) is the physical record of this entire process. It is the first thing an FDA inspector or Notified Body auditor will request. Manufacturers who build their DHF as a collection of unconnected documents — rather than as a traceable record linking inputs to outputs to verification to validation — create significant risk for themselves.

If you are new to building a medical device QMS and need a structured path through these requirements, the ISO 13485 Implementation Roadmap on The Standards Navigator covers the full sequence from gap assessment through certification.

BSI Group offers ISO 13485 training covering both requirements understanding and implementation — useful for teams building their first medical device QMS or transitioning from a general ISO 9001 system.

Labeling and Traceability Standards

Labeling compliance is a specific, frequently cited area in FDA 483 observations. Under both FDA QMSR and MDR requirements, device labeling must meet defined content and format requirements — and the label must be controlled as a quality record.

Key labeling standards and requirements:

ISO 15223-1 — symbols used in medical device labeling (required for EU MDR compliance)
21 CFR Part 801 — FDA labeling requirements for US devices
UDI requirements — FDA requires Unique Device Identification on most device labels, with submission to the GUDID database

Traceability connects directly to your CAPA and complaint handling processes. If a complaint involves a specific lot or device unit, your traceability records must be sufficient to identify affected products, investigate the root cause, and determine corrective action scope. ISO 13485 Clause 7.5.9 addresses traceability explicitly — and auditors will test it.

How the Standards Work Together

Layered medical device compliance standards infographic showing ISO 13485 as the foundation with ISO 14971, FDA QMSR, EU MDR, supplier controls, CAPA, and traceability requirements. — A visual framework showing how ISO 13485, FDA QMSR, EU MDR, and supporting standards connect into an integrated medical device compliance system.

The most important thing to understand about medical device compliance is that these standards are not independent — they form an integrated system. Here is how they connect:

Standard	Role in the System
ISO 13485:2016	QMS framework — the backbone that everything else connects to
ISO 14971:2019	Risk management process — required by ISO 13485, referenced throughout
FDA QMSR	US regulatory layer — builds on ISO 13485, adds FDA-specific requirements
EU MDR	EU regulatory layer — requires ISO 13485 certification via Notified Body
IEC 62304	Software lifecycle — required if your device includes software
ISO 10993	Biocompatibility — required for patient-contacting devices
ISO 15223	Labeling symbols — required for EU MDR labeling compliance

A manufacturer who has ISO 13485 certification, a complete ISO 14971 risk management file, and solid FDA QMSR documentation has built the framework that all additional standards layer onto. The common mistake is treating each standard as a separate compliance project rather than building the integrated system first.

If you are deciding between prioritizing FDA QMSR or ISO 13485 certification first: in most cases, building to ISO 13485 gives you the QMS foundation that both US and EU regulatory compliance require. The ISO 13485 Documentation Requirements article covers what your QMS documentation set must include.

Quick Compliance Checklist

Use this as a starting reference — not a substitute for a clause-by-clause gap assessment.

✅ ISO 13485:2016 obtained and QMS scope defined
✅ Risk management procedure in place referencing ISO 14971
✅ Design controls documented — inputs, outputs, verification, validation, transfer
✅ CAPA process established with effectiveness verification
✅ Supplier qualification and monitoring program documented
✅ Document and record control procedures in place with defined retention periods
✅ Internal audit program scheduled and resourced
✅ Management review process defined and conducted
✅ Complaint handling and MDR/vigilance reporting process established
✅ UDI requirements evaluated and implemented where applicable
✅ Applicable special process validations identified and documented
✅ Labeling reviewed against ISO 15223 (EU) and 21 CFR Part 801 (US)

⚠️ If you cannot check most of these — complete a formal gap assessment before committing to a certification timeline.

FAQ

Is ISO 13485 certification required to sell medical devices?

ISO 13485 certification is not legally required by US law — the FDA requires QMSR compliance, not ISO 13485 certification specifically. However, ISO 13485 certification is required to sell devices in the EU under MDR, and it is increasingly required by OEM customers and contract manufacturers as a condition of doing business. Most manufacturers targeting both markets pursue certification.

How is ISO 13485 different from ISO 9001?

ISO 13485 is a sector-specific standard derived from ISO 9001 but with significantly stricter requirements in risk management, design controls, CAPA, supplier controls, and regulatory compliance. It does not include the continual improvement emphasis that ISO 9001 requires — instead it focuses on consistent compliance with regulatory requirements. A detailed comparison is covered here.

Do I need ISO 14971 if I am ISO 13485 certified?

Yes. ISO 13485 explicitly requires risk management throughout the product lifecycle and references ISO 14971 as the applicable method. You are not ISO 13485 compliant if your risk management process does not meet ISO 14971 requirements. The two standards work together — you cannot separate them.

What is the FDA QMSR and how is it different from the old QSR?

The Quality Management System Regulation (QMSR) took effect February 2, 2026 and replaced 21 CFR Part 820 (the Quality System Regulation). The QMSR incorporates ISO 13485:2016 by reference, making it more aligned with the international standard. Key differences remain around FDA-specific reporting requirements, UDI obligations, and 21 CFR Part 11 electronic records requirements. A full breakdown of FDA QSR vs ISO 13485 is here.

How long does it take to get ISO 13485 certified?

For a manufacturer building a QMS from scratch, 12–18 months is a realistic timeline. Organizations with an existing ISO 9001 QMS can often close the gap in 6–12 months, depending on how many medical device-specific requirements need to be added. The ISO 13485 Implementation Roadmap covers the full timeline in detail.

What is a Notified Body and do I need one?

A Notified Body is an organization designated by EU member states to assess conformity of medical devices under the MDR. If you are seeking CE marking for Class IIa, IIb, or Class III devices, you must engage a Notified Body — they conduct the audits that verify ISO 13485 compliance and technical documentation. BSI Group is one of the major Notified Bodies offering both training and certification services.

What are the most common ISO 13485 audit findings?

The most frequently cited areas include: inadequate document and record control (Clause 4.2), incomplete CAPA processes with missing effectiveness verification (Clause 8.5.2), insufficient supplier qualification documentation (Clause 7.4), and gaps in design control records — particularly missing design verification and validation evidence (Clause 7.3). Common mistakes in ISO 13485 QMS implementation covers these in detail.

Do my suppliers need to be ISO 13485 certified?

Not necessarily — but you are responsible for ensuring purchased product meets specifications regardless. Whether a supplier needs ISO 13485 certification depends on their criticality and what they supply. Critical component suppliers and contract manufacturers of finished devices are typically expected to be certified. Commodity suppliers may only require documented incoming inspection.

📥 Free Resources

ISO 13485 Gap Assessment Checklist — free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements — medical device articles only

ISO 9001 Roadmap — step-by-step implementation guide for manufacturers building or improving a quality management system

Manufacturing Compliance Checklist — practical compliance reference covering key ISO, OSHA, and quality requirements for production environments

Supplier Quality Checklist — evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts

AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification

Not Sure What to Do Next?

🔹 Still researching your compliance requirements? Start with a gap assessment against ISO 13485 before you invest in implementation. Download the free ISO 13485 Gap Assessment Checklist — it maps every clause so you know exactly where you stand.

🔹 Ready to build your QMS? ISO 13485 training through BSI Group covers requirements, implementation, and internal auditor training — the right sequence for a team building their first medical device QMS.

🔹 Need the standard itself? Buy ISO 13485:2016 through the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026. International buyers can purchase in multiple languages.

Medical device compliance is not a single standard — it is a framework of interconnected requirements that must be built and maintained as a system. Understanding how ISO 13485, ISO 14971, FDA QMSR, and EU MDR relate to each other is the first step toward building a QMS that holds up under audit. The Standards Navigator covers each of these standards in depth — start with the resources above and build from there.

Stay Current on Medical Device Compliance

Regulatory changes in the medical device space don’t slow down. FDA QMSR took effect in 2026. EU MDR enforcement is intensifying. ISO 14971 continues to be misapplied by manufacturers who treat risk management as a documentation exercise rather than an integrated process.

Organizations that keep pace with these changes have one thing in common — they’re not waiting for an audit finding to tell them something changed. The ones that struggle are managing compliance reactively, updating their QMS only when a customer or inspector forces the issue.

The Standards Navigator covers ISO 13485, ISO 14971, FDA regulatory requirements, and the full medical device compliance framework — from standard purchase through certification and ongoing surveillance.

👉 Get updates when new medical device compliance articles publish
👉 Be first to access the ISO 13485 Documentation Kit when it launches

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

ISO 13485 Implementation Roadmap: How to Build a Compliant Medical Device QMS in 2026

ISO 13485:2016 is now US federal law under the FDA QMSR, making a compliant medical device QMS mandatory rather than optional. This roadmap walks manufacturers through a seven-phase implementation — from gap assessment and scope through risk management, documentation, CAPA, and certification — covering both the international certification path and FDA inspection readiness for US manufacturers building from the ground up.

A step-by-step guide to implementing ISO 13485:2016 — from gap assessment to certification and FDA QMSR readiness

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

Building a Medical Device QMS Is No Longer Optional in the United States

For years, ISO 13485 sat in a strange position for US manufacturers. It was the global benchmark for medical device quality management — required to sell in the EU, Canada, and most of the world — but inside the United States it was voluntary. You complied with FDA’s Quality System Regulation, and ISO 13485 was a nice-to-have for export.

That changed on February 2, 2026. FDA’s Quality Management System Regulation (QMSR) took effect, replacing the old Quality System Regulation and incorporating ISO 13485:2016 by reference directly into 21 CFR Part 820. The practical effect is blunt: ISO 13485:2016 is now part of US federal law. FDA inspections are conducted against it. The standard you could once ignore at home is now the framework your inspector arrives with.

So whether you are a US manufacturer preparing for your first QMSR-aligned FDA inspection, or an international supplier chasing your first ISO 13485 certificate to unlock the EU market, you face the same task: build a quality management system that survives outside scrutiny. This roadmap walks you through it — clause by clause, phase by phase — from the day you decide to start to the day a registrar or an FDA investigator walks through the door.

This ISO 13485 implementation roadmap is a long article because building a medical device QMS is a long project. Use the table of contents to jump to where you are.

Before you build anything, find out where you actually stand. Most teams overestimate how compliant their existing processes are — and discover the gaps during the certification audit or FDA inspection, when fixing them is expensive and the clock is running. Run a clause-by-clause check against ISO 13485:2016 first.

👉 Download the free ISO 13485 Gap Assessment Checklist and benchmark your QMS in an afternoon, before you commit budget to implementation.

In This Guide

Why ISO 13485 implementation looks different in 2026 (QMSR, EU reforms)
The realistic timeline and cost of a full implementation
A seven-phase roadmap from gap assessment to certificate
How risk management (ISO 14971) and design controls fit into the QMS
The documentation you actually need — and where teams over-build
Internal audit, management review, and Stage 1 / Stage 2 audit preparation
FDA QMSR inspection readiness for US manufacturers
The mistakes that fail audits — and how to avoid them

👉 Start Here (Top Resources)

If you are implementing ISO 13485 from scratch, these are the three resources that move the project fastest:

Build your documentation without a consultant. A complete, pre-written ISO 13485 documentation kit gives you the quality manual, procedures, and records templates structured to the standard — so you spend your time tailoring, not drafting from a blank page. 👉 See the ISO 13485 documentation kits at 9001Simplified
Get the official standard. You cannot implement a clause you have not read. Buy ISO 13485:2016 from the ANSI Webstore — use code CC2026 for 5% off through December 31, 2026. ANSI serves international buyers and offers standards in multiple languages.
Train your internal team. Your management representative and internal auditors need formal training. BSI Group offers ISO 13485 training courses spanning awareness through lead auditor.

What Makes 2026 Different

ISO 13485:2016 is still the current edition — and it will be for a while. ISO postponed the next revision deliberately to let the 2016 edition “bed in,” with a new version not expected before roughly 2028–2029. So the standard you implement today is the standard you will operate under for years. That stability is good news: it means your implementation work has a long shelf life.

What has shifted is the regulatory context around the standard.

In the United States, the QMSR is the headline. FDA now incorporates ISO 13485:2016 into 21 CFR Part 820, layered with a handful of FDA-specific additions — labeling, UDI, and certain record and definition provisions — that go beyond the ISO text. A critical nuance: the QMSR is “version locked” to the 2016 edition. Future ISO 13485 revisions will not automatically apply in the US unless FDA initiates new rulemaking. Certification to ISO 13485 is still not legally required in the US — FDA inspects you directly — but building your QMS to the standard is now the most direct path to QMSR compliance.

In the European Union, the pressure point is notified body capacity, not the standard itself. EU Implementing Regulation 2026/977, published in May 2026 and applying from February 25, 2027, finally imposes hard maximum timelines on notified bodies — 30 days to review an application and sign a contract, 120 days for the QMS audit, 90 days for product verification, and 20 days to issue the certificate, with capped clock-stops and transparent quotations. For manufacturers, the message is that the certification path is becoming more predictable, but you still need a clean, audit-ready QMS to take advantage of it.

One more 2026 wrinkle worth flagging if your devices touch biocompatibility: FDA’s recognition of the sixth edition of ISO 10993-1 is partial. Notably, FDA does not recognize Clause 6.9 on biological risk estimation, holding that it conflicts with the recognized risk management standard ISO 14971:2019. If your risk files cite ISO 10993-1 wholesale, that is now a deficiency-letter risk in US submissions. Keep biological risk inside the ISO 14971 framework. We cover biocompatibility in depth separately — for this roadmap, just know that your risk management process is the anchor, not the 10993 series.

If you sell only in the US → build to ISO 13485:2016 for QMSR compliance and skip certification unless a customer demands it. If you sell internationally → you need an actual ISO 13485 certificate from an accredited registrar, so plan for a Stage 1 / Stage 2 audit. If you sell in both markets → build one QMS to ISO 13485:2016 and bolt on the FDA-specific QMSR additions; do not run two parallel systems.

QMSR vs ISO 13485 at a Glance

The two frameworks now share a core, but they are not identical. This is where US and international readers diverge — and where a single well-built QMS can serve both.

Dimension	ISO 13485:2016	FDA QMSR (21 CFR Part 820)
Legal status	Voluntary international standard	Mandatory US federal regulation
Core requirements	The full ISO 13485 QMS	Incorporates ISO 13485:2016 by reference
Proof of compliance	Certificate from accredited registrar	FDA inspection — no certificate issued
Added requirements	None beyond the standard	Labeling, UDI, certain records & definitions
Risk management	References ISO 14971	Requires ISO 14971 framework; rejects ISO 10993-1 Clause 6.9
Version handling	ISO may revise (~2028–2029)	“Version locked” to the 2016 edition
Who needs it	Anyone selling internationally	Any device manufacturer marketing in the US

For the full treatment, see our dedicated FDA QSR vs ISO 13485 comparison.

Timeline and Cost: What to Expect

A realistic ISO 13485 implementation runs 6 to 12 months for a small-to-mid-size manufacturer building from a limited starting point. Companies already operating a mature ISO 9001 system or a legacy QSR-based system can move faster; companies starting from informal processes should plan for the full year.

ISO 13485 implementation timeline infographic showing a phased 6 to 12 month roadmap for medical device manufacturers progressing from gap assessment through certification. — A visual roadmap showing a realistic ISO 13485 implementation timeline from assessment through certification readiness.

Phase	Typical duration	What drives it
Gap assessment & scope	2–4 weeks	Size of the gap between current practice and the standard
Process & documentation build	8–16 weeks	Whether you draft from scratch or start from templates
Implementation & operation	8–12 weeks	You need real records, not just documents — audits want evidence
Internal audit & management review	3–4 weeks	Must be complete before a registrar will proceed to Stage 2
Certification (Stage 1 + Stage 2)	6–10 weeks	Registrar scheduling and any nonconformity closure

On cost, the single biggest variable is whether you hire a consultant to draft your system or build it yourself from a structured template. Consultant-led implementations commonly run $15,000–$50,000+ depending on device class and company size. A template-driven build can cut the documentation labor dramatically. For a full breakdown, see our guide on how much ISO 13485 certification costs.

Phase 1 — Foundation: Scope, Standard, and Leadership Commitment

Everything downstream depends on getting three things right at the start.

Define your QMS scope. ISO 13485 lets you exclude certain requirements — for example, design and development (Clause 7.3) if you are a contract manufacturer building to a customer’s design. But exclusions must be justified and documented, and you cannot exclude something just because it is inconvenient. Map which clauses apply to your role: manufacturer, specification developer, contract manufacturer, sterilization provider, or importer. Your scope statement is the first thing a registrar reads and the boundary an FDA investigator works within.

Acquire and read the standard. This sounds obvious and gets skipped constantly. You cannot delegate compliance with a document nobody on the team has read end to end. Buy the official ISO 13485:2016 text from the ANSI Webstore — apply coupon CC2026 for 5% off through the end of 2026 — and have your management representative work through it clause by clause. If you also need the risk management standard, ISO 14971:2019 is available there too. ANSI’s catalog covers international buyers and multiple languages, which matters if your QMS spans sites.

Secure genuine leadership commitment. Clause 5 puts top management on the hook — quality policy, quality objectives, resource allocation, and management review are not delegable to a quality manager working in isolation. The fastest implementations have an executive sponsor who clears roadblocks. The ones that stall have a quality team trying to impose a system the leadership treats as paperwork.

If you are a contract manufacturer → document your design and development exclusion now, with justification, before you build the rest of the system around it.

⚠️ Common pitfall: Claiming a Clause 7.3 exclusion you can’t defend. If your team does any design input — even tweaking a customer’s spec for manufacturability — a registrar may reject the exclusion and you’ll be retrofitting design controls mid-project. Decide your true scope honestly before you build.

Most ISO 13485 projects don’t fail on the standard — they fail on documentation that nobody can find, follow, or defend in an audit. Before you write a single procedure, make sure you know which records the standard actually requires.

👉 Run the gap assessment and map your existing documents against the clauses — it turns “we think we’re covered” into a defensible list.

Phase 2 — Plan: Processes, Roles, and Competence

ISO 13485 is a process-based standard. Before documentation, map your actual processes and how they connect — the “sequence and interaction” the standard requires.

Identify your core processes. At minimum: management processes (planning, review, resourcing), product realization (design, purchasing, production, servicing), and support processes (document control, records, CAPA, internal audit). For each, define inputs, outputs, owners, and the records that prove it ran.

Appoint a management representative. Clause 5.5.2 requires a member of management responsible for the QMS. This person owns the system, reports its performance to leadership, and is typically the registrar’s main point of contact.

Plan competence and training. Clause 6.2 requires that personnel performing work affecting product quality are competent — with records to prove it. This includes your internal auditors, who must be trained and independent of the areas they audit. Formal training shortens the learning curve here; BSI Group’s ISO 13485 course catalog runs from awareness through lead auditor, and the lead-auditor tier is what equips your internal audit program to find problems before the registrar does. For audit methodology itself, note that the underlying guidance standard, ISO 19011, was updated to a 2026 edition in May 2026 — worth referencing when you write your internal audit procedure.

⚠️ Common pitfall: Treating internal auditor “independence” as a formality. Having someone audit their own department is one of the most common nonconformities — and it quietly undermines every finding that audit produces. Cross-train auditors so no one reviews work they own.

Phase 3 — Risk Management and Design Controls

This is where ISO 13485 separates itself from ISO 9001, and where the most consequential implementation decisions live.

Risk management is the spine. ISO 13485 threads risk-based thinking through the entire product lifecycle, and it leans on ISO 14971:2019 as the method. You need a risk management process, a risk management file for each device or device family, and evidence that risk controls are verified and monitored in production and post-market. As noted earlier, keep biological risk inside this ISO 14971 framework rather than importing a separate scoring approach — that alignment is exactly what FDA expects under the QMSR.

Design controls (Clause 7.3) apply if you develop devices. This is the discipline FDA investigators scrutinize hardest, because design failures are where patients get hurt. You need:

Design control element	What it requires
Design and development planning	A documented plan with stages, reviews, and responsibilities
Design inputs	Requirements derived from intended use, user needs, and regulation
Design outputs	Specifications that can be verified against inputs
Design review	Formal reviews at planned stages with independent reviewers
Design verification	Evidence outputs meet inputs
Design validation	Evidence the device meets user needs in actual or simulated use
Design transfer	Controlled handoff to production
Design changes	Controlled, reviewed, and documented changes
Design history file (DHF)	The complete record of the above

If you are a US manufacturer, the QMSR keeps design controls firmly in play — they map directly onto the ISO 13485 Clause 7.3 requirements, which is one reason a single ISO-aligned system now serves both purposes.

If you are preparing your first device submission → build the risk management file and design history file in parallel with the QMS, not after. Auditors and investigators expect to see them populated, not planned.

⚠️ Common pitfall: Building the risk file as a one-time document for the submission, then never touching it again. Risk management is a living, lifecycle requirement — production and post-market data have to feed back into it. A risk file frozen at launch is a finding waiting to happen.

Phase 4 — Build the Documentation

Now you write the system. ISO 13485 expects a defined documentation hierarchy: a quality manual, documented procedures, work instructions, forms, and the records they generate.

ISO 13485 documentation architecture infographic showing the five-layer quality management documentation hierarchy from quality manual through records. — A visual breakdown of the five documentation layers used to build and maintain an ISO 13485 quality management system.

The required documents. ISO 13485:2016 explicitly requires certain documented procedures — document control, record control, management review, internal audit, control of nonconforming product, CAPA, and several product-realization procedures among them. A medical device file (technical documentation) is required for each device type. Our breakdown of ISO 13485 documentation requirements lists exactly what the standard mandates versus what is optional.

Where teams over-build. The most common documentation mistake is writing procedures more detailed and rigid than the operation can actually follow. Every sentence in a procedure is a commitment an auditor can hold you to. If your procedure says calibration happens every 90 days and a record shows 95, that is a nonconformity you created with your own words. Write to what you do; improve what you do separately.

Start from a structured template, not a blank page. Drafting an entire ISO 13485 documentation set from scratch is where 6-month projects become 12-month projects. A complete documentation kit gives you the quality manual, every required procedure, and the records templates already structured to the clauses — so your team spends its hours tailoring language to your operation instead of reinventing the architecture of a QMS.

👉 See what’s included in the 9001Simplified ISO 13485 documentation kit — it is the no-consultant route most small manufacturers should evaluate first.

Set up document and record control before you generate volume. Clauses 4.2.4 and 4.2.5 require controlled documents and controlled records. Get the control mechanism — versioning, approval, retention, retrieval — working before you have hundreds of documents to retrofit.

⚠️ Common pitfall: Over-documenting. Teams write procedures so detailed and rigid that the floor can’t actually follow them — then every deviation from their own paperwork becomes a nonconformity. Document what you genuinely do, keep procedures lean, and push the specifics down into work instructions where they’re easier to change.

Phase 5 — Implement and Operate

A documented QMS proves nothing. Auditors and investigators want records that show the system ran.

This is the phase teams underestimate. You can write a CAPA procedure in a day; demonstrating that CAPA actually works requires real CAPAs opened, investigated, and closed over weeks. Plan for an operating period — typically 8 to 12 weeks minimum — where the system runs and generates genuine evidence: training records, calibration records, completed reviews, supplier evaluations, nonconformance reports, and CAPA records.

A registrar will not progress to a certification audit, and an FDA investigator will not be satisfied, by documents alone. Both want to trace a process from requirement to record to outcome. Build that evidence trail before you invite anyone to inspect it.

If you are under customer pressure to certify quickly → start operating the system in parallel with finishing documentation, so your evidence trail is already accumulating when the documents are signed off.

⚠️ Common pitfall: Booking the certification audit before the system has actually run. A registrar can tell the difference between a QMS that has operated for three months and one that generated all its records last week. Backdated or thin evidence is the fastest way to turn a Stage 2 audit into a list of nonconformities.

Phase 6 — CAPA, Supplier Controls, and Production Controls

Three areas generate the most audit findings and FDA 483 observations. Get them right and you de-risk the entire certification.

CAPA (Corrective and Preventive Action). This is the single most-cited area in medical device QMS audits. A weak CAPA system — actions opened and never closed, root causes not actually identified, effectiveness never verified — signals to an auditor that the whole system is decorative. Your CAPA process must show genuine root cause analysis, defined actions, and verified effectiveness. Our deep dive on CAPA requirements in ISO 13485 covers the failure modes in detail.

Supplier and purchasing controls (Clause 7.4). You are accountable for what your suppliers provide. You need defined supplier evaluation criteria, approved-supplier records, and controls proportionate to the risk the purchased product carries. Flow your quality requirements down in writing — handshake arrangements do not survive audits.

Production and process controls (Clauses 7.5). This includes process validation for any process whose output cannot be fully verified by later inspection — sterilization and certain welding or molding processes are classic examples — plus identification, traceability, and handling of product. Cleanliness, contamination control, and installation/servicing requirements apply where relevant to your device.

A documentation kit accelerates this layer too. The CAPA log, supplier evaluation forms, nonconformance records, and validation templates are exactly the high-stakes documents you do not want to invent under deadline.

👉 A structured kit gives you defensible templates for all three areas so your effort goes into running the processes, not formatting the paperwork.

Avoid the recurring traps documented in our guide to common mistakes in ISO 13485 QMS implementation — most failures are predictable.

⚠️ Common pitfall: Closing CAPAs without verifying effectiveness. “We retrained the operator” is not a closed CAPA — it’s an action with no proof it worked. Auditors reopen these constantly. Every CAPA needs a defined effectiveness check and evidence it passed before you close it.

Phase 7 — Internal Audit, Management Review, and Certification

Before any external party inspects you, inspect yourself.

Internal audit (Clause 8.2.4). Conduct a full internal audit of your QMS against ISO 13485 using trained, independent auditors. This is your dress rehearsal — the audit that finds problems while you still control the timeline and the narrative. Document findings, open CAPAs, and close them.

Management review (Clause 5.6). Top management formally reviews QMS performance against defined inputs — audit results, customer feedback, process performance, CAPA status, and more — and produces documented outputs and decisions. Registrars treat a missing or hollow management review as a serious gap.

The certification audit (international path). An accredited registrar conducts a two-stage audit:

Stage	Focus	Outcome
Stage 1	Documentation review and readiness	Confirms the system is ready for Stage 2; identifies gaps
Stage 2	On-site implementation audit	Verifies the system operates as documented; raises any nonconformities

Close any nonconformities, and the registrar issues your certificate — typically valid for three years with annual surveillance audits. Choosing an accredited registrar matters; verify accreditation through bodies like ANAB or the relevant IAF member. Our guide to the best ISO certification bodies walks through selection.

⚠️ Common pitfall: Running a hollow management review to check the box. A review that doesn’t actually examine audit results, CAPA status, and process performance — and produce real decisions — is treated by registrars as a serious gap, because it signals leadership isn’t engaged. Make it substantive, and keep the minutes.

FDA QMSR Inspection Readiness

If you are a US manufacturer, your “certification audit” may instead be an FDA inspection — and the bar is the QMSR, which now runs on ISO 13485:2016 plus FDA’s additions.

Practical readiness steps:

Map ISO 13485 to the QMSR additions. Most of your ISO-aligned system satisfies Part 820 directly. Layer in the FDA-specific requirements — labeling and packaging controls, UDI, and certain record and complaint-handling provisions — that exceed the ISO text.
Keep your records inspection-ready, not audit-ready-once. FDA inspections are unannounced or short-notice. The evidence trail from Phase 5 has to be standing, not assembled on demand.
Treat CAPA and complaint handling as the focal points. These are where 483 observations concentrate. A clean, closed-loop CAPA system is your strongest signal of control.
Understand the relationship between the two frameworks. Our comparison of FDA QSR vs ISO 13485 explains exactly what the QMSR changed and where the frameworks now align.

For US manufacturers selling internationally, the efficient move is one ISO 13485 QMS with the QMSR additions built in — not two systems. The frameworks now overlap by design.

Quick Implementation Checklist

Use this as a high-level progress tracker. Each item maps to a phase above.

✅ QMS scope defined and exclusions justified in writing
✅ Official ISO 13485:2016 (and ISO 14971:2019) acquired and read
✅ Top management commitment secured; quality policy and objectives set
✅ Management representative appointed
✅ Core processes mapped with owners, inputs, outputs, and records
✅ Personnel competence and internal auditor training in place
✅ Risk management process and risk management file established (ISO 14971)
✅ Design controls and design history file in place (if you develop devices)
✅ Quality manual, required procedures, and record templates written
✅ Document control and record control operating before volume builds
✅ System operated long enough to generate genuine records (8–12 weeks)
✅ CAPA system demonstrably closing the loop with verified effectiveness
✅ Supplier evaluation and purchasing controls documented and flowed down
✅ Process validation completed where output can’t be fully verified
✅ Full internal audit completed; findings closed
✅ Management review conducted with documented outputs
✅ Registrar selected (international) or QMSR inspection readiness confirmed (US)
✅ Stage 1 and Stage 2 audit passed; nonconformities closed

FAQ

How long does ISO 13485 implementation take?

For a small-to-mid-size manufacturer building from a limited starting point, plan for 6 to 12 months. Companies with a mature ISO 9001 system or a legacy QSR-based system can move faster, while organizations starting from informal processes should plan for the full year. The longest single phase is usually documentation, followed by the operating period needed to generate real records.

Is ISO 13485 certification required in the United States?

No. FDA inspects US manufacturers directly against the QMSR, which incorporates ISO 13485:2016 — certification by a third-party registrar is not legally required. However, building your QMS to ISO 13485 is now the most direct path to QMSR compliance, and certification is required to sell in the EU, Canada, and most international markets. Many US manufacturers certify anyway to serve global customers and demonstrate a recognized standard of control.

What is the difference between ISO 13485 and the FDA QMSR?

The QMSR, effective February 2, 2026, replaced FDA’s old Quality System Regulation and incorporates ISO 13485:2016 by reference into 21 CFR Part 820, plus FDA-specific additions covering labeling, UDI, and certain records. The two are now largely aligned by design. The QMSR is “version locked” to the 2016 edition, so future ISO 13485 revisions will not automatically apply in the US. See our full FDA QSR vs ISO 13485 comparison for detail.

Do I need ISO 14971 to implement ISO 13485?

Effectively, yes. ISO 13485 threads risk-based thinking through the product lifecycle and relies on the methodology in ISO 14971:2019 for risk management. You need a documented risk management process and a risk management file for each device. We explain the relationship in ISO 14971 vs ISO 13485.

Can a contract manufacturer exclude design controls?

Yes, if you build strictly to a customer’s design and do not perform design and development activities. ISO 13485 permits excluding Clause 7.3, but the exclusion must be justified and documented in your QMS scope. You cannot exclude a requirement simply because it is burdensome — only because it genuinely does not apply to your role.

What causes most ISO 13485 audit findings?

CAPA weaknesses lead the list — actions that never close, root causes not genuinely identified, and effectiveness never verified. Document and record control, supplier controls, and process validation are also frequent finding areas. Our guide to common ISO 13485 QMS mistakes covers the recurring patterns.

Should I hire a consultant or use a documentation kit?

It depends on device class, internal capacity, and budget. Consultant-led implementations offer hands-on guidance but commonly run $15,000–$50,000 or more. A structured documentation kit gives you the full QMS architecture — manual, procedures, and record templates — at a fraction of that cost, so your team tailors rather than drafts from scratch. Many small manufacturers start with a kit and bring in targeted consulting only for device-specific risk and design questions.

What is ISO 13485 and who needs it?

ISO 13485 is the international quality management system standard for organizations involved in the medical device lifecycle — design, production, storage, distribution, installation, and servicing. It applies to manufacturers, specification developers, contract manufacturers, sterilization providers, and importers. Our primer, What Is ISO 13485?, covers the fundamentals.

📥 Free Resources

Practical tools to support your implementation — download what fits your project:

ISO 13485 Gap Assessment Checklist — free checklist for medical device manufacturers assessing their QMS against ISO 13485 requirements, clause by clause, before committing to implementation.
ISO 9001 Roadmap — step-by-step implementation guide for organizations building or improving a quality management system, useful if you operate an ISO 9001 base alongside 13485.
Manufacturing Compliance Checklist — practical compliance reference covering key ISO, OSHA, and quality requirements for production environments.
Supplier Quality Checklist — evaluation tool for assessing supplier quality controls and flow-down compliance before audits or new contracts.
AS9100 Rev D Gap Assessment Checklist — 74-item clause-by-clause checklist for aerospace suppliers assessing their QMS before certification, for teams operating across aerospace and medical device lines.

Not Sure What to Do Next?

Your next step depends on where you are in the project:

🔹 If you haven’t assessed your gap yet → start with the free ISO 13485 Gap Assessment Checklist. Don’t commit budget to implementation until you know the size of the gap.
🔹 If you’re ready to build documentation → evaluate a complete ISO 13485 documentation kit before paying consultant rates to draft from scratch. It is the fastest route to an audit-ready document set for most small manufacturers.
🔹 If you’re comparing the US and international paths → read FDA QSR vs ISO 13485 and how much ISO 13485 costs to scope budget and timeline before you choose.

Building an ISO 13485 QMS is a real project, but it is a known one. The clauses are fixed, the phases are sequential, and the failure modes are predictable. Move through it in order, build real evidence as you go, and inspect yourself before anyone else does — and a certification audit or FDA inspection becomes a confirmation, not a gamble. The Standards Navigator exists to make exactly this kind of industrial compliance work clear and survivable for the people who have to actually do it.

Most teams don’t fail ISO 13485 because they misunderstand the standard — they fail because they assumed they were compliant and found out during the audit. The organizations that struggle treat the QMS as paperwork to satisfy a registrar. The organizations that succeed treat it as the operating system that proves their devices are safe — and they build evidence from day one.

The Standards Navigator covers medical device compliance from QMSR readiness to risk management, CAPA, and certification — written from operational and quality management experience, not generic theory.

👉 Get updates on medical device QMS, ISO 13485, and FDA QMSR compliance
👉 Be first to access new gap assessment tools, documentation guides, and implementation resources

Subscribe below to stay ahead.

The Standards Navigator — Industrial Compliance. Clearly Explained.

ISO 13485 Documentation Requirements (2026)

Every document and record ISO 13485 requires — with clause references, document control requirements under Section 4.2, record retention rules, how QMSR changed the documentation landscape, and the seven gaps auditors find most consistently. Built as a reference document quality managers can use before their next audit.

Every document your QMS must have, what auditors check first, and why the gaps between your procedures and your records are where most findings live.

Last Updated: May 2026

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Binder on the Shelf Is Not a QMS

Years ago, working in a nuclear component facility, I watched a certification audit go sideways in the first thirty minutes. The quality manager had spent six months building what looked like a complete quality management system — binders, procedures, forms, the works. The auditor asked to see the document register. The quality manager pointed to the binder. The auditor asked how documents were controlled at the point of use. The quality manager pointed to the binder again.

The binder was the system. It sat on a shelf in the quality office. The machinists on the floor had printed copies of procedures from three years prior. Nobody had a current revision of anything. The audit did not go well.

ISO 13485 documentation is not about having paperwork. It is about having the right documents, in the right format, accessible to the right people, at the right time — and being able to prove all of that during an audit. The standard is specific about what must be documented, what must be retained as records, and what that documentation must demonstrate.

Under QMSR, which took effect February 2, 2026, FDA now evaluates ISO 13485 documentation requirements against the framework directly. Organizations that treat documentation as a filing exercise rather than a quality system function are finding that gap at inspection.

This article covers every documentation requirement ISO 13485 imposes, where auditors look first, and what a compliant documentation system actually looks like in practice.

In This Guide

The difference between documents and records under ISO 13485 — and why it matters for audits
Every mandatory document the standard requires
Every mandatory record the standard requires
Document control requirements under Section 4.2
Record retention rules under Section 4.2.5
The most common documentation gaps auditors find
How QMSR changed the documentation landscape for U.S. medical device manufacturers
Decision-stage guidance for organizations at different points in their documentation journey

Start Here (Top Resources)

🔖 Get ISO 13485:2016 → ANSI Webstore — ANSI is the official U.S. distributor of ISO standards, ensuring you receive the controlled, compliant version required for certification audits. Use coupon CC2026 for 5% off.

🔖 Build compliant QMS documentation → 9001Simplified — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

🔖 Train your team on ISO 13485 documentation requirements → BSI Group — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

🔖 Pursue or maintain ISO 13485 certification → ISOQAR — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

Browse the What Is ISO 13485? pillar article for full clause context, or use the ISO 13485 Gap Assessment Checklist to identify your specific documentation gaps before your next audit.

Documents vs. Records: The Distinction That Drives Compliance

ISO 13485 treats documents and records as separate categories with different requirements. Confusing them is one of the most consistent sources of documentation findings in surveillance audits.

Documents are instructions, procedures, specifications, and plans — the things that tell people what to do. They are living documents: they can be revised, updated, and superseded. Section 4.2.4 governs their control.

Records are evidence that something was done — completed forms, test results, inspection reports, calibration data, training sign-offs. They are fixed in time: once a record is created, it cannot be altered without creating a documented amendment. Section 4.2.5 governs their control.

The practical distinction matters for two reasons. First, the control requirements differ. Documents need revision control, approval, distribution, and obsolescence management. Records need legibility, identification, storage protection, retrieval, and defined retention periods. A documentation system that applies the same controls to both will have gaps in one or the other.

Second, auditors evaluate them separately. When an auditor asks for a procedure, they are asking for a document. When they ask for evidence, they are asking for a record. Handing an auditor a completed form when they asked for a procedure — or a procedure when they asked for evidence — signals a documentation system that does not understand its own structure.

At this point, most quality managers building or auditing a documentation system should: → Map your document inventory against your record inventory separately. If your document register includes completed forms alongside controlled procedures, your system architecture has a structural problem. 9001Simplified’s documentation kits include pre-structured document and record registers built for ISO 13485 compliance. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

Mandatory Documents Under ISO 13485

ISO 13485 requires specific documented procedures and plans across multiple clauses. These are not optional — certification bodies audit for their existence and their content.

ISO 13485 documentation infographic illustrating mandatory quality management system documents with interconnected process icons for quality manuals, risk management, design planning, procedures, records retention, purchasing controls, and document control requirements. — Certification bodies expect documented procedures, controlled records, and defined plans that demonstrate the quality system operates consistently and remains audit ready — see the full list in the table below.

Document	Clause	What It Must Cover
Quality Manual	4.2.2	Scope of the QMS, exclusions with justification, documented procedures or references, description of QMS process interactions
Document Control Procedure	4.2.4	Approval, review, revision control, distribution, obsolescence management, external documents
Records Control Procedure	4.2.5	Identification, storage, protection, retrieval, retention periods, disposition
Management Review Procedure	5.6	Inputs, outputs, frequency, documentation requirements
Competence, Training & Awareness Procedure	6.2	How competence is determined, how training is delivered, how competence is evaluated and recorded
Infrastructure Procedure	6.3	Maintenance of buildings, equipment, and supporting services affecting product quality
Work Environment Procedure	6.4	Control of work environment conditions where required for product conformity
Risk Management Procedure	7.1	Risk management process across the product lifecycle, per ISO 14971
Customer-Related Processes Procedure	7.2	Requirements determination, review, and customer communication
Design & Development Procedure	7.3	Planning, inputs, outputs, review, verification, validation, transfer, changes (if design is not excluded)
Purchasing Procedure	7.4	Supplier evaluation, selection, monitoring, and purchasing information
Production & Service Controls Procedure	7.5	Control of production and service provision, cleanliness, installation, and servicing
Identification & Traceability Procedure	7.5.3	Product identification throughout realization and traceability requirements
Customer Property Procedure	7.5.4	Control and safeguarding of customer-supplied product or data
Preservation Procedure	7.5.5	Preservation of product during processing and delivery
Monitoring & Measurement Equipment Procedure	7.6	Calibration, verification, and control of measuring equipment
Feedback Procedure	8.2.1	Post-market surveillance and feedback collection
Complaint Handling Procedure	8.2.2	Complaint receipt, investigation, and regulatory reporting decisions
Internal Audit Procedure	8.2.4	Audit planning, conduct, reporting, and follow-up
Nonconforming Product Procedure	8.3	Identification, segregation, evaluation, and disposition
CAPA Procedure	8.5.2 / 8.5.3	Corrective and preventive action process, including root cause analysis and effectiveness verification

⚠️ If your organization excludes design and development under Clause 7.3, that exclusion must be justified in the Quality Manual and documented. Exclusions without documented justification are a consistent finding in initial certification audits.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Mandatory Records Under ISO 13485

Records are the evidence your QMS operated as documented. The standard specifies which records must be maintained — these are the minimum. Your procedures may require additional records.

Record	Clause	What It Must Demonstrate
Management Review Minutes	5.6.3	Inputs reviewed, decisions made, actions assigned with owners and timelines
Education, Training, Skills & Experience	6.2	Competence evaluated, training completed, results recorded
Infrastructure Maintenance	6.3	Maintenance activities and results for quality-critical equipment
Risk Management Records	7.1	Risk analysis, risk evaluation, risk control, residual risk assessment, post-production monitoring
Customer Requirements Review	7.2.2	Requirements determined and confirmed before commitment
Design & Development Records	7.3	Inputs, outputs, reviews, verifications, validations, transfer, and changes (if not excluded)
Design & Development Changes	7.3.9	Change description, evaluation, verification, validation, approval
Supplier Evaluation Records	7.4.1	Evaluation criteria, results, and re-evaluation decisions
Production Process Validation	7.5.2	Validation protocols, results, equipment qualifications
Traceability Records	7.5.3.2	Unique device identification and traceability through production
Customer Property Records	7.5.4	Receipt, condition assessment, and disposition of customer property
Calibration Records	7.6	Equipment identification, calibration standard, results, next due date
Internal Audit Records	8.2.4	Audit plans, findings, nonconformances, corrective actions, follow-up
Product Monitoring & Measurement	8.2.6	Evidence of conformity and identification of release authority
Nonconforming Product Records	8.3	Nature of nonconformity, disposition decision, concession records if applicable
CAPA Records	8.5.2 / 8.5.3	Root cause analysis, action taken, effectiveness verification with criteria and evidence

➡️ 9001Simplified Documentation Kits — Pre-built ISO 13485 procedures, forms, and record templates covering every mandatory document and record listed above. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

Document Control: What Section 4.2.4 Actually Requires

Section 4.2.4 sets out seven specific requirements for document control. Each one has a practical implementation implication — and each one is evaluated individually during audits.

1. Documents must be approved before use. Approval must be by authorized personnel. Your document control procedure must define who has approval authority for each document type. A document approved by someone outside that authority — or with no documented approval at all — is a nonconformance.

2. Documents must be reviewed, updated as necessary, and re-approved. Review frequency should be defined in your procedure. Documents that have never been reviewed since initial creation are a finding in surveillance audits — particularly if the regulatory environment or production process has changed.

3. Changes and current revision status must be identified. Every controlled document needs a revision identifier — a number, letter, or date — and your document register needs to reflect current revision status. Auditors check this against what is in use.

4. Relevant versions must be available at points of use. This is the binder-on-the-shelf failure. Current controlled versions must be accessible where work is performed. If people work from printed copies, you need a controlled printing process. If work is performed on a production floor, current procedures must be accessible there — not only in the quality office.

5. Documents must be legible and identifiable. This sounds obvious. It is consistently violated by organizations that allow handwritten annotations, informal updates, or degraded printed copies to remain in service.

6. External documents must be identified and controlled. This includes customer drawings, regulatory guidance documents, referenced standards, and supplier specifications. External documents that affect product quality must be listed in your document control system and their current version verified.

7. Obsolete documents must be prevented from unintended use. Obsolete documents must either be removed from all points of use or clearly marked as obsolete. Finding an active workstation with a superseded procedure is a major nonconformance — regardless of whether anyone was actually using it.

If you are under active FDA inspection pressure → BSI Group ISO 13485 Training covers document control implementation and audit preparation in depth. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

Record Retention: What Section 4.2.5 Actually Requires

Section 4.2.5 requires that records be retained for a period at least equal to the lifetime of the medical device, but not less than two years from the date of product release by the organization.

That two-year floor is the minimum. In practice, most medical device records should be retained significantly longer:

Implantable devices — the device lifetime may span decades. Records need to match.
Devices with long service lives — the same logic applies.
FDA QMSR requirements — align with ISO 13485 on the two-year minimum but your complaint handling procedure may require longer retention for MDR-related records.
Customer contractual requirements — OEM customers increasingly specify record retention periods in their supplier quality agreements. These requirements take precedence where they are more stringent than the standard’s minimum.

Your records control procedure must define retention periods for each record type. A blanket “two years” policy applied to all records — including design history files and risk management records for long-life devices — is not compliant.

Provider	What You Get	Best For
ANSI Webstore	ISO 13485:2016 official standard	Any organization needing the controlled, compliant version of the standard
9001Simplif i ed	QMS documentation kits with record templates	Organizations building documentation from scratch or rebuilding after a major finding
BSI Group	ISO 13485 training courses	Teams implementing documentation systems or preparing for initial certification
ISOQAR	ISO 13485 certification	Organizations ready to pursue or maintain certification

Most organizations building documentation systems from scratch need all three:

The standard from ANSI Webstore (use CC2026 for 5% off)
Lead implementer training from BSI Group
A documentation kit from 9001Simplified

This combination covers the standard, the knowledge, and the implementation infrastructure.

The Most Common Documentation Gaps

ISO 13485 documentation gaps infographic illustrating seven common audit findings, including outdated document registers, incomplete supplier records, weak CAPA evidence, missing procedures, and disconnected risk management records within medical device quality systems. — Documentation failures rarely appear as isolated findings. They create chains of audit problems across CAPA, supplier controls, training, management review, and risk management. The gap is usually discovered long after it was created.

These are the findings that appear most consistently in ISO 13485 surveillance audits and QMSR inspections. Each one points to a specific procedure or record requirement.

The Quality Manual references procedures that don’t exist. A common initial certification shortcut is writing a Quality Manual that references a full set of documented procedures — then discovering during the surveillance audit that several of those procedures were never finalized. The Quality Manual and the document register must be synchronized.

The document register is not current. Document registers that haven’t been updated in months, that show revision numbers inconsistent with what is in use, or that are missing entire document categories are a consistent finding. The register is the first thing many auditors check.

Risk management records stop at design transfer. ISO 14971 requires risk management across the product lifecycle. Design-phase risk files with no post-production updates — no connection to complaint data, service reports, or CAPA findings — are incomplete regardless of how thorough the original analysis was. See ISO 14971 vs ISO 13485 for the full lifecycle requirement.

CAPA records close without effectiveness verification evidence. A CAPA record that reads “action implemented — problem resolved” with no supporting data is not a closed CAPA — it is an open finding waiting to be issued. For the complete breakdown of what effectiveness verification requires, see CAPA Requirements in ISO 13485.

Supplier qualification records are incomplete or outdated. An approved supplier list without corresponding qualification evidence, or qualification records for suppliers whose scope has changed without requalification, are consistently cited findings under Clause 7.4.

Training records prove attendance, not competence. Sign-off sheets showing who attended a training session are not competence records. The record must show what competence was evaluated, by what method, and what the result was. See Common Mistakes in ISO 13485 QMS for the full breakdown of this finding.

Management review minutes record presentations, not decisions. Minutes that describe what was presented in management review without documenting what was decided are a major finding under Section 5.6.3. Every input reviewed must produce a documented output — a decision, an action, or a rationale for no action.

How QMSR Changed the Documentation Landscape

FDA’s Quality Management System Regulation, effective February 2, 2026, aligns U.S. medical device QMS requirements with ISO 13485:2016. For documentation, the practical changes are significant.

The Device Master Record (DMR) structure is now explicitly required. Under QMSR, the DMR — which must include device specifications, production process specifications, quality assurance procedures, packaging and labeling specifications, and installation and maintenance procedures — is a specific documentation requirement that ISO 13485 certification alone does not fully address.

Complaint files under 21 CFR 820.198 remain a separate requirement. ISO 13485 requires a complaint handling procedure. QMSR additionally requires that complaint files contain specific elements — including the decision on whether the complaint required investigation and, if so, the results of that investigation — that go beyond what most ISO 13485 complaint procedures specify.

MDR procedures must be documented separately. Medical Device Reporting obligations are a regulatory requirement that sits outside ISO 13485 but must be addressed in your QMS documentation under QMSR.

⚠️ FDA QMSR compliance date was February 2, 2026. If your documentation system has not been reviewed against the four QMSR-specific bridge requirements since that date, that review is overdue. The ISO 13485 Gap Assessment Checklist covers all four QMSR bridge requirements explicitly alongside the standard ISO 13485 clause requirements.

For the full regulatory alignment picture, see FDA QSR vs ISO 13485.

Infographic explaining the major operational and regulatory changes introduced under the FDA QMSR, including terminology alignment, expanded risk management, inspection changes, and ISO 13485 document control requirements. — The FDA’s QMSR transition introduced major changes beyond terminology — expanding risk management expectations, changing inspection structure, and aligning medical device quality systems directly with ISO 13485.

Why Organizations Delay Getting Documentation Right

“We’ll clean it up before the surveillance audit.”

This is the most common delay rationalization — and it consistently produces the worst outcomes. Documentation gaps that accumulate over 11 months cannot be credibly remediated in the 30 days before a surveillance visit. Auditors can identify recently created records. A CAPA file dated three weeks before the audit for a problem that complaint data shows has existed for eight months is not evidence of a functioning QMS — it is evidence of audit preparation, which auditors treat as a different category of finding.

“Our documentation was good enough for initial certification.”

Initial certification evaluates documentation at a point in time against a system that was built to be audited. Surveillance audits evaluate whether that system has been maintained — which means they look at records created since the last audit, not at procedures written before it. Organizations that passed initial certification and then stopped maintaining their documentation systems often face multiple major nonconformances at the first surveillance visit.

“We don’t have the internal resources to build this properly.”

This objection is real — but the cost of building documentation properly before certification is substantially lower than the cost of remediation after a major nonconformance. A documentation kit from 9001Simplified covers every mandatory document and record template in a ready-to-use format. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch. The internal labor required to customize a pre-built kit is a fraction of what is required to build from scratch — and a fraction of what remediation costs after a finding.

Frequently Asked Questions

What documents are required by ISO 13485?

ISO 13485 requires documented procedures covering quality manual, document control, records control, management review, training and competence, risk management, customer requirements, purchasing, production controls, identification and traceability, calibration, feedback, complaint handling, internal audit, nonconforming product, and CAPA. The full list with clause references is in the Mandatory Documents table above.

What records are required by ISO 13485?

ISO 13485 requires records covering management reviews, training and competence evaluations, risk management activities, design and development (if not excluded), supplier evaluations, calibration, internal audits, product monitoring, nonconforming product dispositions, and CAPA activities. The full list with clause references is in the Mandatory Records table above.

How long must ISO 13485 records be retained?

The standard requires retention for at least the lifetime of the device, with a minimum of two years from product release. For implantable devices and devices with long service lives, the retention period is typically longer and should be defined in your records control procedure. FDA QMSR aligns with this minimum but specific record types — particularly MDR-related records — may require longer retention.

Does ISO 13485 require a Quality Manual?

Yes. Section 4.2.2 requires a Quality Manual that defines the scope of the QMS, documents or references procedures, and describes the interactions between QMS processes. The Quality Manual is one of the first documents an auditor requests.

Can we use electronic records to meet ISO 13485 requirements?

Yes — electronic records are acceptable provided your document control system ensures they are controlled, legible, retrievable, and protected from unauthorized modification. Electronic systems used to manage controlled documents must themselves be validated if they affect product quality.

What is the difference between a controlled document and a record under ISO 13485?

A controlled document is an instruction, procedure, or specification that tells people what to do — it can be revised and must be version-controlled. A record is evidence that something was done — it is fixed in time and must be retained according to your records control procedure. Section 4.2.4 governs controlled documents; Section 4.2.5 governs records. The distinction is fundamental to building a compliant documentation system.

Does design and development documentation apply to all medical device manufacturers?

Only if the manufacturer performs design and development activities. If your organization manufactures to customer specifications and does not perform design activities, you may be eligible to exclude Clause 7.3 — but that exclusion must be documented and justified in your Quality Manual. Contract manufacturers who claim a 7.3 exclusion without justification are consistently cited at initial certification.

How do FDA QMSR documentation requirements differ from ISO 13485?

QMSR aligns with ISO 13485 but adds four specific requirements: the Device Master Record structure, complaint files under 21 CFR 820.198, Medical Device Reporting procedures, and corrections and removals procedures. ISO 13485 certification alone does not cover these four requirements. The ISO 13485 Gap Assessment Checklist addresses all four explicitly.

What is the first thing an auditor looks at for ISO 13485 documentation?

Most auditors start with the document register — to verify that controlled documents are listed, revision levels are current, and the register reflects what is actually in use. From there they move to the Quality Manual to verify scope and procedure references. Gaps in either of those two items typically expand the audit’s scope significantly.

Free Resources

📋 Free Download: Manufacturing Compliance Checklist — ISO 9001, 14001, 45001 & OSHA — 50 items with gap scoring across all systems.

📋 Free Download: Supplier Quality Checklist — ISO 9001 Clause 8.4 — all supplier controls auditors evaluate, 45 items with scoring.

📋 Free Download: ISO 9001 Implementation Roadmap — The exact 5-phase process from gap assessment to Stage 2 audit clearance.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Not Sure What to Do Next?

→ You need the official ISO 13485:2016 standard → ANSI Webstore — Use CC2026 for 5% off. ANSI is the official U.S. distributor of ISO standards.

→ You need to build ISO 13485 documentation from scratch → 9001Simplified Documentation Kits — ready-to-use procedures, forms, and record templates for every mandatory document.

→ You need to train your team on documentation requirements → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses.

→ You are ready to pursue ISO 13485 certification → ISOQAR — UKAS-accredited, one of the most recognized certification bodies in the industry.

→ You need to assess your documentation gaps before your next audit → ISO 13485 Gap Assessment Checklist — free, 64 items.

→ You need to understand how QMSR changed your documentation obligations → FDA QSR vs ISO 13485

→ You need to understand CAPA record requirements in depth → CAPA Requirements in ISO 13485

→ You need to understand the most common documentation audit findings → Common Mistakes in ISO 13485 QMS

→ You need to understand how risk management documentation connects to your QMS → ISO 14971 vs ISO 13485

→ You need to understand the full ISO 13485 clause structure → What Is ISO 13485?

→ You want to buy ISO 13485 → Buy ISO 13485

→ You want to browse all medical device standards → explore standards by compliance area

Still figuring out where to start?

If you are not ready to commit to a documentation build yet — that is normal. Most organizations spend several weeks between identifying gaps and starting remediation.

The best next step: → Download the free ISO 13485 Gap Assessment Checklist — it takes 20 minutes and tells you exactly which documents and records you are missing before you spend anything.

Feature image promoting an ISO 13485 Gap Assessment Checklist for medical device manufacturers, contract manufacturers, and component suppliers preparing for certification and FDA QMSR compliance. — ISO 13485 Gap Assessment Checklist designed to help medical device manufacturers identify compliance gaps, prioritize actions, and prepare for certification and FDA QMSR requirements.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Binder Is Not the System

Documentation is not ISO 13485’s most technically demanding requirement. But it is the foundation every other requirement rests on. Without controlled documents, procedures cannot be consistently followed. Without records, there is no evidence that procedures were followed at all. Without a document control system that connects what is written to what people actually use, the gap between those two things grows quietly — until an auditor measures it.

The organizations that handle documentation audits well are not the ones with the most sophisticated quality management software or the thickest procedure binders. They are the ones whose documentation reflects how work actually gets done — current, accessible, and connected to the records that prove it.

That alignment takes discipline to build and discipline to maintain. It does not take complexity.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

Subscribe below to stay ahead.

Common Mistakes in ISO 13485 QMS (2026)

Seven ISO 13485 QMS mistakes that consistently produce major nonconformances — document control drift, management review gaps, supplier qualification failures, CAPA records closed without verification, risk management treated as a one-time activity, competence records that prove attendance not ability, and internal audits that never find anything. With clause references and fixes for each.

The audit findings that derail medical device manufacturers — and the fixes that prevent them.

Last Updated: May 2026

Affiliate Disclosure: Some links in this article are affiliate links. If you purchase through them, The Standards Navigator may earn a commission at no additional cost to you.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Your QMS Passed Initial Certification. Now the Surveillance Audit Found Three Major Nonconformances.

This scenario plays out more often than most quality managers expect.

Initial certification audits are thorough — but they happen at a fixed point in time, against a QMS that was built specifically to pass them. Surveillance audits arrive 12 months later and evaluate how the system actually operates day to day. That gap between what was built and what runs is where most findings live.

The mistakes in this article are not obscure edge cases. They are the findings that certification bodies issue most consistently, that FDA investigators flag most frequently under QMSR, and that experienced quality practitioners see repeated across organizations of every size. Some of them look like documentation failures. Most of them are process failures wearing documentation’s clothes.

If you are preparing for a first certification audit, a surveillance visit, or an FDA QMSR inspection, this list tells you where to look before the auditor does.

In This Guide

The most common mistakes in ISO 13485 QMS by clause
Why document control failures are almost never about documents
The management review gap that catches organizations by surprise
How supplier qualification problems compound over time
What auditors find when they look at CAPA records
The risk management connection most QMS procedures miss
Decision-stage guidance for organizations at different points in their compliance journey

Start Here (Top Resources)

🔖 Train your team on ISO 13485 → BSI Group — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

🔖 Pursue or maintain ISO 13485 certification → ISOQAR — ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

Browse the What Is ISO 13485? pillar article for full clause context, or use the ISO 13485 Gap Assessment Checklist to identify your specific gaps before your next audit.

Mistake 1: Document Control That Controls Nothing

The clause: ISO 13485 Section 4.2 — Document Control

What auditors find: Obsolete procedures still accessible in shared drives. Forms in use that don’t match the current controlled version. Employees working from printed copies with no revision date. Documents approved by someone whose role no longer includes that authority.

Document control failures are the most consistently cited finding in ISO 13485 surveillance audits — not because organizations don’t have document control procedures, but because those procedures don’t match how people actually access and use documents day to day.

The standard requires that documents be reviewed and approved before use, that current versions are available at points of use, and that obsolete documents are prevented from unintended use. Each of those three requirements has failed in organizations that had a document control procedure on file.

The fix: Document control is an access problem, not a paperwork problem. The question is not “do we have a procedure?” — it’s “can an employee working right now reach a document that has been superseded?” If the answer is yes, your document control system is not functioning regardless of what your procedure says.

Audit your access architecture — shared drives, QMS software, printed SOPs at workstations — before an auditor does. Every document a user can reach should be the current controlled version. Everything else should require deliberate action to retrieve.

At this point, most quality managers in this position should: → Pull your document control procedure and map it against actual employee access. If those two things don’t match, 9001Simplified’s documentation kits include document control templates built specifically for ISO 13485 compliance. 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

Mistake 2: Management Review Without Documented Outputs

The clause: ISO 13485 Section 5.6 — Management Review

What auditors find: Meeting minutes that record attendance and agenda items but contain no documented decisions. Review inputs listed without evidence they were actually analyzed. Action items described without owners, deadlines, or follow-up records. Reviews conducted annually when the organization’s risk profile warranted more frequent review.

ISO 13485 Section 5.6.3 is explicit: management review outputs must include decisions and actions related to improvement of the QMS, improvement of product to meet customer requirements, and resource needs. A management review that happened but produced no documented decisions is a nonconformance — regardless of what was discussed in the room.

This finding catches organizations off guard because the review itself felt thorough. Leadership reviewed quality objectives, discussed complaint trends, walked through audit results. But the meeting minutes read like a summary of what was presented, not a record of what was decided.

The fix: Management review outputs need to look like decisions, not summaries. For each input reviewed, the record should show: what the data indicated, what conclusion was reached, and what — if anything — will be done about it. “Complaint trend reviewed — no action required” is a decision. “Complaint data presented” is not.

⚠️ Under QMSR, FDA inspectors now evaluate management review as part of every inspection. Inspectors who find management reviews without documented outputs routinely cite this as a systemic QMS failure, not an administrative lapse.

Mistake 3: Supplier Qualification on Paper Only

ISO 13485 supplier qualification infographic illustrating risk-based supplier controls under Clause 7.4, featuring a supplier risk tier matrix, qualification lifecycle process, ongoing monitoring activities, and common supplier management mistakes. — Supplier qualification under ISO 13485 is not a one-time approval exercise. Risk classification, qualification activities, performance monitoring, and periodic re-evaluation must work as a continuous lifecycle.

The clause: ISO 13485 Section 7.4 — Purchasing / Supplier Controls

What auditors find: An approved supplier list that has not been updated in years. Suppliers qualified based on a questionnaire with no follow-up evaluation. Critical suppliers with no documented performance monitoring. Qualification records for suppliers whose scope of supply has expanded beyond what was originally evaluated.

Supplier qualification failures compound over time in a way that most other QMS failures don’t. A supplier that was qualified five years ago may have changed ownership, changed manufacturing processes, changed subcontractors, or expanded into new product categories — none of which triggered a requalification because the procedure didn’t require one.

ISO 13485 requires that purchasing controls be proportionate to the risk the supplier presents to product quality and patient safety. That proportionality has to be reflected in your qualification criteria, your monitoring frequency, and your records. An approved supplier list populated with names and no evaluation data is not a supplier qualification program.

The fix: Supplier qualification is a living process, not a one-time gate. Your procedure should define evaluation criteria by supplier risk tier, monitoring frequency, requalification triggers, and what happens when a supplier fails to meet performance criteria. If you are using the Supplier Quality Checklist, the ISO 13485 Clause 7.4 section identifies every supplier control element auditors evaluate — including the ones most procedures leave undocumented.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items covering ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Mistake 4: CAPA Records That Close Without Verification

ISO 13485 CAPA infographic comparing incorrect and correct closure methods, showing the difference between closing corrective actions without effectiveness verification and closing them with documented objective evidence under Clause 8.5.2. — CAPA is not complete when action is implemented. Under ISO 13485 Clause 8.5.2, closure requires effectiveness verification supported by defined criteria, monitoring, objective evidence, and documented results.

The clause: ISO 13485 Section 8.5.2 — Corrective Action

What auditors find: CAPAs closed at implementation with no effectiveness check. Effectiveness verifications that consist of a single sentence — “action implemented, problem resolved” — with no supporting data. Criteria for effectiveness that were defined after the action was taken rather than before. The same problem recurring in a subsequent audit cycle.

Closing a CAPA without effectiveness verification is one of the most consistently cited major nonconformances in ISO 13485 audits. The standard requires that corrective actions be reviewed for effectiveness — and that review must be documented, must use defined criteria, and must be supported by evidence.

The pattern most organizations fall into is treating CAPA closure as an administrative step rather than a quality decision. Someone implements the action, marks the record complete, and moves on. The question “did this actually work?” never gets formally answered.

The fix: Effectiveness verification criteria must be established before the corrective action is implemented — not after. The criteria should be specific enough that a different person reviewing the record could objectively determine whether they were met. “No recurrence for 90 days” is a criterion. “Situation improved” is not.

For a complete breakdown of CAPA requirements under ISO 13485 Clause 8.5.2 — including the InfuTronix case study and the six mandatory data inputs under Section 8.4 — see CAPA Requirements in ISO 13485.

➡️ BSI Group ISO 13485 Training — Covers CAPA, supplier controls, management review, and all major ISO 13485 clauses. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

Mistake 5: Risk Management Treated as a One-Time Activity

The clause: ISO 13485 Section 7.1 / ISO 14971

What auditors find: Risk files created during design and never updated. Post-market surveillance data that has no documented connection to risk management. Field failures that triggered a CAPA but never prompted a review of the corresponding risk file. Risk management plans that reference ISO 14971 but contain no evidence of post-production monitoring.

Risk management documentation under Clause 7.1 is now the top QMSR inspection finding — 25 citations in the first three months of QMSR inspection data, ahead of CAPA. That displacement reflects a systematic failure in how most organizations treat risk: as a design-phase activity rather than a lifecycle responsibility.

ISO 14971 is explicit that risk management extends across the entire product lifecycle. Post-market surveillance data, complaint trends, service reports, and CAPA findings are all risk management inputs. When those data sources exist in separate systems with no documented connection to the risk file, the risk management process is incomplete — regardless of how thorough the original risk analysis was.

The fix: Your risk management procedure should define how post-production information feeds back into risk files. When a complaint trend reaches a defined threshold, when a CAPA is opened for a field failure, when a service report pattern emerges — each of those events should trigger a documented review of the relevant risk analysis. That review should produce a documented decision: residual risk is still acceptable, or risk control measures need updating.

For the full picture of how ISO 14971 and ISO 13485 interact at the clause level, see ISO 14971 vs ISO 13485.

Mistake 6: Training Records That Prove Attendance, Not Competence

The clause: ISO 13485 Section 6.2 — Human Resources / Competence

What auditors find: Training records that show who attended a session and when, with no evidence of what was covered or whether it was understood. Competence assessments that consist of a supervisor signature with no evaluation criteria. Personnel performing quality-critical tasks without documented evidence that they are qualified to do so. New employees signed off on procedures they completed training on — but with no record of how competence was evaluated.

ISO 13485 Section 6.2 requires that personnel performing work affecting product quality are competent — and that competence is evaluated and the results are recorded. Attendance is not competence. Completing a training module is not competence. Competence is the demonstrated ability to apply knowledge and skills to produce the required outcome.

This distinction becomes a major finding when an auditor pulls the training record for someone who made a quality-critical decision and finds a sign-off sheet.

The fix: Competence evaluation needs defined criteria for each quality-critical role — what knowledge and skill is required, and how it will be evaluated. That evaluation can be a practical demonstration, a written assessment, a supervised work period with documented sign-off, or another method appropriate to the task. The key is that the record shows what was evaluated and what the result was — not just that training occurred.

If you are building competence frameworks from scratch, BSI Group’s ISO 13485 training courses include role-based competency models that align with Section 6.2 requirements. BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses, recognized by certification bodies globally.

Mistake 7: Internal Audits That Don’t Find Anything

The clause: ISO 13485 Section 8.2.4 — Internal Audit

What auditors find: Internal audit programs that audit the same low-risk processes repeatedly while avoiding the areas where problems actually exist. Audit reports that describe observations as “satisfactory” or “no issues found” across every clause. Internal auditors who have never issued a nonconformance. Audit findings that are consistently minor and never escalate to CAPA.

An internal audit program that finds nothing is either auditing the wrong things or auditing them incorrectly. Certification bodies and FDA investigators specifically look at the output of your internal audit program — not just whether audits were conducted on schedule. If your internal audit findings never trigger a CAPA and never surface anything your surveillance audit finds, that incongruence is a finding in itself.

ISO 13485 requires that the internal audit program take into account the status and importance of the processes to be audited and the results of previous audits. A risk-based audit program will allocate more frequency and depth to high-risk processes — CAPA, supplier controls, complaint handling, design controls — and less to lower-risk administrative processes.

The fix: Evaluate your internal audit program against what your surveillance audits and FDA inspections have actually found. If there is a consistent gap — if surveillance audits find things your internal audits missed — that gap is the finding. Your audit program needs to be harder on the areas that matter most, not easier.

If you need to develop your internal audit capability, ISOQAR offers ISO 13485 internal auditor training and certification support. ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

At this point, most quality managers preparing for their next audit should: → Cross-reference your last three internal audit reports against your last surveillance audit finding. If the surveillance audit found something your internal audits missed, that’s the gap to close first. Get the ISO 13485 Gap Assessment Checklist to run a structured review across all clauses.

Common Misconceptions About ISO 13485 QMS

ISO 13485 infographic illustrating common misconceptions about quality management systems, comparing myths versus reality around certification, QMSR alignment, and major nonconformances in medical device quality systems. — Some of the most expensive ISO 13485 mistakes begin as assumptions. Certification is not a finish line, ISO 13485 and QMSR are not identical, and a major nonconformance does not automatically mean certification loss.

“Passing initial certification means the QMS is compliant.”

Initial certification confirms that a QMS met the standard’s requirements at a specific point in time, as evaluated against a specific set of records. Surveillance audits evaluate whether the system continues to operate as documented. Organizations that build a QMS to pass initial certification and then don’t maintain it operationally consistently accumulate findings by the first surveillance audit. Certification is not a destination — it is a recurring obligation.

“ISO 13485 and FDA QMSR requirements are now the same thing.”

QMSR, which took effect February 2, 2026, aligns FDA’s device QMS requirements with ISO 13485 — but does not make them identical. Four FDA-specific requirements exist in QMSR that ISO 13485 certification alone does not cover: complaint files under 21 CFR 820.198, MDR procedures, corrections and removals, and the device master record structure. An organization that is ISO 13485 certified is not automatically QMSR compliant. The ISO 13485 Gap Assessment Checklist covers all four QMSR bridge requirements explicitly.

“A major nonconformance means we will lose certification.”

A major nonconformance means the certification body has identified a significant gap in the QMS — one that has the potential to affect product quality or patient safety. It does not automatically result in suspension or withdrawal of certification. It triggers a corrective action requirement with a defined response timeline. Organizations that respond with a documented root cause analysis and credible corrective action plan typically resolve major nonconformances without losing certification. The risk is not the finding — it is the failure to respond adequately.

Frequently Asked Questions

What is the most common ISO 13485 audit finding?

Document control failures under Section 4.2 are consistently the most common finding in surveillance audits. CAPA effectiveness verification failures and management review output gaps follow closely. Under QMSR inspections, risk management documentation under Clause 7.1 is now the leading finding.

How many nonconformances are typical in an ISO 13485 surveillance audit?

There is no typical number. A mature QMS with active internal audit and CAPA programs may receive zero nonconformances. A QMS that has been maintained administratively rather than operationally may receive multiple majors. What matters is whether findings from one audit cycle are genuinely closed before the next one.

What is the difference between a major and minor nonconformance in ISO 13485?

A major nonconformance indicates a systematic failure that has the potential to affect product quality or patient safety — or the complete absence of a required process. A minor nonconformance indicates an isolated lapse or a process weakness that does not constitute a systematic failure. Major nonconformances require a documented corrective action plan with a defined response timeline. Minor nonconformances are typically addressed at the next surveillance audit.

Can we self-declare ISO 13485 compliance without certification?

Self-declaration against ISO 13485 is not recognized in the medical device industry in the way it is sometimes used in other sectors. Customers, regulatory bodies, and OEMs expect third-party certification from an accredited body. Self-declaration provides no audit trail and no independent verification of compliance. If you are building toward certification, ISOQAR is a UKAS-accredited certification body — one of the most recognized in the industry for ISO management system certification.

How long does it take to fix a major nonconformance?

Certification bodies typically allow 30 to 90 days to respond to a major nonconformance with a documented corrective action plan, evidence of root cause analysis, and initial implementation evidence. Full closure — including effectiveness verification — may take longer depending on the nature of the finding. The timeline should be proposed by the organization and accepted by the certification body.

What is the best way to prepare for an ISO 13485 surveillance audit?

Run a structured internal audit against the clauses most likely to surface findings — Section 4.2 (document control), Section 5.6 (management review), Section 7.4 (supplier controls), Section 8.2.4 (internal audit), and Section 8.5.2 (CAPA). Pull a sample of CAPA records and verify that effectiveness verifications are complete. Review your management review minutes for documented outputs. Check that your approved supplier list reflects current qualification status. The ISO 13485 Gap Assessment Checklist covers all of this in 64 structured items.

Do these mistakes also apply under FDA QMSR?

Yes — and in some cases the stakes are higher. QMSR inspections evaluate every subsystem, every inspection. Document control failures, CAPA gaps, and management review deficiencies that might result in a minor nonconformance from a certification body can result in a 483 observation or warning letter from FDA. See FDA QSR vs ISO 13485 for the full regulatory alignment picture.

Free Resources

📋 Free Download: Manufacturing Compliance Checklist — ISO 9001, 14001, 45001 & OSHA — 50 items with gap scoring across all systems.

📋 Free Download: Supplier Quality Checklist — ISO 9001 Clause 8.4 — all supplier controls auditors evaluate, 45 items with scoring.

📋 Free Download: ISO 9001 Implementation Roadmap — The exact 5-phase process from gap assessment to Stage 2 audit clearance.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

Not Sure What to Do Next?

→ You need the official ISO 13485:2016 standard → ANSI Webstore — Use CC2026 for 5% off. ANSI is the official U.S. distributor of ISO standards.

→ You need to assess your QMS gaps before your next audit → ISO 13485 Gap Assessment Checklist — free, 64 items

→ You need to build or rebuild QMS documentation → 9001Simplified Documentation Kits — 9001Simplified provides ready-to-use documentation kits that dramatically reduce the internal labor required to build a compliant QMS from scratch.

→ You need to train your team on ISO 13485 requirements → BSI Group ISO 13485 Training — BSI Group is a founding member of ISO and one of the world’s largest providers of ISO training courses.

→ You are ready to pursue or maintain ISO 13485 certification → ISOQAR — UKAS-accredited, one of the most recognized certification bodies in the industry.

→ You need to understand CAPA requirements in depth → CAPA Requirements in ISO 13485

→ You need to understand how risk management connects to your QMS → ISO 14971 vs ISO 13485 and What Is ISO 14971?

→ You need to understand how QMSR changed your compliance obligations → FDA QSR vs ISO 13485

→ You need to understand what ISO 13485 covers at the clause level → What Is ISO 13485?

→ You need to understand the cost of ISO 13485 certification → How Much Does ISO 13485 Cost?

→ You want to buy ISO 13485 → Buy ISO 13485

→ You want to browse all medical device standards → explore standards by compliance area

Still figuring out where to start?

If you are not ready to invest in training or documentation yet — that is normal. Most organizations take several weeks to move from identifying gaps to committing to a remediation plan.

The best next step for most organizations at this stage: → Download the free ISO 13485 Gap Assessment Checklist — it takes 20 minutes and tells you exactly where your QMS has gaps before you spend anything.

📋 Free Download: ISO 13485 Gap Assessment Checklist — 64 items — ISO 13485 clauses + all four FDA QMSR bridge requirements ISO 13485 certification alone does not cover.

The Gap Between What Was Built and What Runs

Most ISO 13485 QMS failures are not failures of intent. The organizations that receive major nonconformances typically built their systems with genuine effort. What they built, however, was optimized for initial certification — not for the ongoing operational reality that surveillance audits and FDA inspections evaluate.

Document control systems that work at go-live drift as people find workarounds. CAPA programs that close records efficiently lose track of effectiveness. Management reviews that felt thorough produce minutes that record what was presented rather than what was decided. None of these failures are dramatic. They accumulate quietly, and they surface at the worst possible time.

The difference between a QMS that passes surveillance audits consistently and one that doesn’t is not sophistication. It is the discipline to evaluate what the system actually does — not just what the procedures say it does — on a regular basis.

At The Standards Navigator, complex standards are translated into practical, real-world guidance you can act on.

Subscribe below to stay ahead.

Your Risk Management File Is the First Thing an Auditor Opens

In This Guide

Table of Contents

👉 Start Here: Top Resources for Medical Device Risk Management

What ISO 14971:2019 Requires

How ISO 13485 Clause 7.1 Connects

The Five-Stage Risk Management Process

Stage 1: Risk Management Plan

Stage 2: Risk Analysis

Stage 3: Risk Evaluation

Stage 4: Risk Control

Stage 5: Residual Risk and Benefit-Risk Analysis

Setting Acceptable Risk Criteria

Risk Control Options and Residual Risk

The Risk Management File

Post-Production Information and Surveillance

Common Audit Findings in Risk Management Reviews

Training for Your Risk Management Team

FAQ

What is the difference between ISO 14971 and ISO 13485 for risk management?

Is ISO 14971 mandatory?

What is a risk management file?

How often should a risk management file be updated?

What risk analysis methods does ISO 14971 require?

What is the difference between a hazard, a hazardous situation, and harm in ISO 14971?

How does ISO 14971 relate to CAPA in ISO 13485?

What changed in ISO 14971:2019 compared to the 2007 edition?

📥 Free Resources

Not Sure What to Do Next?

Stay Current on Medical Device Compliance

Subscribe

The Standard That Guided ISO 13485 Compliance Is Gone — Here’s What That Means

In This Guide

Table of Contents

👉 Start Here — Top Resources

What Was ISO/TR 14969?

Why Was ISO/TR 14969 Withdrawn?

What Replaced ISO/TR 14969? Structure and Clause Mapping

Why This Matters More in 2026: FDA QMSR and Dual Compliance

How to Update Your QMS for Current Guidance

✅ Quick Checklist: ISO/TR 14969 Reference Review

Where to Buy ISO 13485 and the Current Guidance Handbook

FAQ

Is ISO/TR 14969 still valid?

What replaced ISO/TR 14969?

Can I still reference ISO/TR 14969 in my QMS procedures?

Does ISO/TR 14969 apply to FDA QMSR compliance?

What is the difference between a Technical Report and an ISO standard?

How is ISO/TR 14969 different from ISO 13485?

Do I need to buy the ISO 13485:2016 Practical Guide separately from the standard?

Where can I get ISO 13485 training that covers the current guidance?

📥 Free Resources

Not Sure What to Do Next?

Stay Current on ISO 13485 and Medical Device Compliance

Subscribe

The Compliance Gap That Gets Medical Device Manufacturers in Trouble

Table of Contents

The Core Standard: ISO 13485:2016

Risk Management: ISO 14971:2019

US Regulatory Requirements: FDA QMSR and 21 CFR Part 820

EU Requirements: MDR and CE Marking

Supplier Controls and Special Process Standards

Design Controls and Validation Standards

Labeling and Traceability Standards

How the Standards Work Together

Quick Compliance Checklist

FAQ

Is ISO 13485 certification required to sell medical devices?

How is ISO 13485 different from ISO 9001?

Do I need ISO 14971 if I am ISO 13485 certified?

What is the FDA QMSR and how is it different from the old QSR?

How long does it take to get ISO 13485 certified?

What is a Notified Body and do I need one?

What are the most common ISO 13485 audit findings?

Do my suppliers need to be ISO 13485 certified?

📥 Free Resources

Not Sure What to Do Next?

Stay Current on Medical Device Compliance

Subscribe

Building a Medical Device QMS Is No Longer Optional in the United States